Exempt Chemical Preparations Under the Controlled Substances Act
Summary
The Drug Enforcement Administration (DEA) has issued a notice regarding exempt chemical preparations under the Controlled Substances Act. This notice opens a 60-day public comment period for interested parties to submit their views on the matter.
What changed
The Drug Enforcement Administration (DEA) has published a notice concerning chemical preparations that may be exempt from the Controlled Substances Act. This notice initiates a 60-day public comment period, allowing stakeholders to provide input on the classification and regulation of these substances. The specific details of the proposed exemptions or the scope of the notice are not fully elaborated in the provided text, but it pertains to substances regulated under the Controlled Substances Act.
Regulated entities, particularly manufacturers and distributors of chemical preparations, should review this notice and consider submitting comments by the deadline of May 19, 2026. Failure to participate in the comment period may result in the final rule not reflecting the entity's operational needs or concerns. The DEA is seeking public input to inform its regulatory decisions regarding these exempt preparations.
What to do next
- Review the DEA notice regarding exempt chemical preparations.
- Submit comments by the May 19, 2026 deadline if applicable.
- Consult legal counsel regarding potential impacts on chemical product lines.
Source document (simplified)
Legal Status This site displays a prototype of a “Web 2.0” version of the daily
Federal Register. It is not an official legal edition of the Federal
Register, and does not replace the official print version or the official
electronic version on GPO’s govinfo.gov.
The documents posted on this site are XML renditions of published Federal
Register documents. Each document posted on the site includes a link to the
corresponding official PDF file on govinfo.gov. This prototype edition of the
daily Federal Register on FederalRegister.gov will remain an unofficial
informational resource until the Administrative Committee of the Federal
Register (ACFR) issues a regulation granting it official legal status.
For complete information about, and access to, our official publications
and services, go to About the Federal Register on NARA's archives.gov.
The OFR/GPO partnership is committed to presenting accurate and reliable
regulatory information on FederalRegister.gov with the objective of
establishing the XML-based Federal Register as an ACFR-sanctioned
publication in the future. While every effort has been made to ensure that
the material on FederalRegister.gov is accurately displayed, consistent with
the official SGML-based PDF version on govinfo.gov, those relying on it for
legal research should verify their results against an official edition of
the Federal Register. Until the ACFR grants it official status, the XML
rendition of the daily Federal Register on FederalRegister.gov does not
provide legal notice to the public or judicial notice to the courts.
Legal Status
Notice
Exempt Chemical Preparations Under the Controlled Substances Act
A Notice by the Drug Enforcement Administration on 03/20/2026
- 1.
1.
This document has a comment period that ends in 60 days.
(05/19/2026) View Comment Instructions
Thank you for taking the time to create a comment. Your input is important.
Once you have filled in the required fields below you can preview and/or submit your comment to the Justice Department for review. All comments are considered public and will be posted online once the Justice Department has reviewed them.
You can view alternative ways to comment or you may also comment via Regulations.gov at /documents/2026/03/20/2026-05486/exempt-chemical-preparations-under-the-controlled-substances-act.
It appears that you have attempted to comment on this document before
so we've restored your progress.
Start over.
1.
2. Comment * What is your comment about? Upload File(s) Note: You can attach your comment as a file and/or attach supporting
documents to your comment. Attachment Requirements.
Email this will NOT be posted on regulations.gov
Opt to receive email confirmation of submission and tracking number? Tell us about yourself! I am... * An Individual An Organization Anonymous First Name * Last Name * City Region State Alabama Alaska American Samoa Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Guam Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Puerto Rico Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virgin Islands Virginia Washington West Virginia Wisconsin Wyoming Zip Country Afghanistan Åland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia, Plurinational State of Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, the Democratic Republic of the Cook Islands Costa Rica Côte d'Ivoire Croatia Cuba Curaçao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Holy See (Vatican City State) Honduras Hong Kong Hungary Iceland India Indonesia Iran, Islamic Republic of Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Korea, Democratic People's Republic of Korea, Republic of Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macao Macedonia, the Former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia, Federated States of Moldova, Republic of Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Northern Mariana Islands Norway Oman Pakistan Palau Palestine, State of Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Réunion Romania Russian Federation Rwanda Saint Barthélemy Saint Helena, Ascension and Tristan da Cunha Saint Kitts and Nevis Saint Lucia Saint Martin (French part) Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten (Dutch part) Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syrian Arab Republic Taiwan, Province of China Tajikistan Tanzania, United Republic of Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States United States Minor Outlying Islands Uruguay Uzbekistan Vanuatu Venezuela, Bolivarian Republic of Viet Nam Virgin Islands, British Virgin Islands, U.S. Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe Phone Organization Type * Company Organization Federal State Local Tribal Regional Foreign U.S. House of Representatives U.S. Senate Organization Name * You are filing a document into an official docket. Any personal
information included in your comment text and/or uploaded
attachment(s) may be publicly viewable on the web. I read and understand the statement above.
- Preview Comment Please review the Regulations.gov privacy notice and user notice.
- Document Details Published Content - Document Details Agencies Department of Justice Drug Enforcement Administration Agency/Docket Number Docket No. DEA-372 Document Citation 91 FR 13610 Document Number 2026-05486 Document Type Notice Pages 13610-13637 (28 pages) Publication Date 03/20/2026 Published Content - Document Details
- PDF Official Content
- View printed version (PDF) Official Content
- Document Details Published Content - Document Details Agencies Department of Justice Drug Enforcement Administration Agency/Docket Number Docket No. DEA-372 Document Citation 91 FR 13610 Document Number 2026-05486 Document Type Notice Pages 13610-13637 (28 pages) Publication Date 03/20/2026 Published Content - Document Details
- Document Dates Published Content - Document Dates Comments Close 05/19/2026 Dates Text Comments must be submitted electronically or postmarked on or before May 19, 2026. Published Content - Document Dates
Table of Contents Enhanced Content - Table of Contents This table of contents is a navigational tool, processed from the
headings within the legal text of Federal Register documents.
This repetition of headings to form internal navigation links
has no substantive legal effect.- AGENCY:
- ACTION:
- SUMMARY:
- DATES:
- ADDRESSES:
- FOR FURTHER INFORMATION CONTACT:
- SUPPLEMENTARY INFORMATION:
- Posting of Public Comments
- Legal Authority
- Exempt Chemical Preparation Applications Submitted Between September 1, 2024, and December 31, 2025
- Scope of Approval
- Opportunity for Comment
- Approved Exempt Chemical Preparations Are Posted on DEA's Website
- Signing Authority
- Footnotes Enhanced Content - Table of Contents
Related Documents Enhanced Content - Related Documents FederalRegister.gov uses the agency dockets published with the document to display related documents.
| Docket No. DEA-372
(15 Documents) | | | |
| --- | | | |
| Date | | Action | Title |
| | 2026-03-20 | Exemption orders with opportunity for comment. | Exempt Chemical Preparations Under the Controlled Substances Act |
| | 2025-07-01 | Order with opportunity for comment. | Exempt Chemical Preparations Under the Controlled Substances Act |
| | 2024-05-15 | Order with opportunity for comment. | Exempt Chemical Preparations Under the Controlled Substances Act |
| | 2023-05-22 | Order with opportunity for comment. | Exempt Chemical Preparations Under the Controlled Substances Act |
| | 2022-08-31 | Order with opportunity for comment. | Exempt Chemical Preparations Under the Controlled Substances Act |
| | 2022-04-19 | Order with opportunity for comment. | Exempt Chemical Preparations Under the Controlled Substances Act |
| | 2022-02-03 | | Exempt Chemical Preparations Under the Controlled Substances Act |
| | 2022-01-21 | Order with opportunity for comment. | Exempt Chemical Preparations Under the Controlled Substances Act |
| | 2021-07-22 | Order with opportunity for comment. | Exempt Chemical Preparations Under the Controlled Substances Act |
| | 2021-04-23 | Order with opportunity for comment. | Exempt Chemical Preparations Under the Controlled Substances Act |
| | 2018-12-03 | Order with opportunity for comment. | Exempt Chemical Preparations Under the Controlled Substances Act |
| | 2017-06-12 | Order with opportunity for comment. | Exempt Chemical Preparations Under the Controlled Substances Act |
| | 2016-05-20 | Order with opportunity for comment. | Exempt Chemical Preparations Under the Controlled Substances Act |
| | 2016-03-25 | Notice of order with opportunity for comment. | Exempt Chemical Preparations Under the Controlled Substances Act |
| | 2013-07-03 | Order with opportunity for comment. | Exempt Chemical Preparations Under the Controlled Substances Act |
Enhanced Content - Related Documents
- Public Comments Enhanced Content - Public Comments Comments are being accepted - View Comment Instructions.
Enhanced Content - Public Comments
- Regulations.gov Data Enhanced Content - Regulations.gov Data Additional information is not currently available for this document.
Enhanced Content - Regulations.gov Data
- Sharing Enhanced Content - Sharing Shorter Document URL https://www.federalregister.gov/d/2026-05486 Email Email this document to a friend Enhanced Content - Sharing
- Print Enhanced Content - Print
- Print this document Enhanced Content - Print
- Other Formats Enhanced Content - Other Formats This document is also available in the following formats:
JSON Normalized attributes and metadata XML Original full text XML MODS Government Publishing Office metadata More information and documentation can be found in our developer tools pages.
Enhanced Content - Other Formats
- Public Inspection Public Inspection This PDF is FR Doc. 2026-05486 as it appeared on Public Inspection on
03/19/2026 at 8:45 am.
It was viewed
30
times while on Public Inspection.
If you are using public inspection listings for legal research, you
should verify the contents of the documents against a final, official
edition of the Federal Register. Only official editions of the
Federal Register provide legal notice of publication to the public and judicial notice
to the courts under 44 U.S.C. 1503 & 1507. Learn more here.
Public Inspection
Published Document: 2026-05486 (91 FR 13610) This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.
Document Headings Document headings vary by document type but may contain
the following:
- the agency or agencies that issued and signed a document
- the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to
- the agency docket number / agency internal file number
- the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details.
Department of Justice
Drug Enforcement Administration
- [Docket No. DEA-372]
AGENCY:
Drug Enforcement Administration, Department of Justice.
ACTION:
Exemption orders with opportunity for comment.
SUMMARY:
The applications for exempt chemical preparations received by the Drug Enforcement Administration between September 1, 2024, and December 31, 2025, as listed below, were accepted for filing and have been approved or denied as indicated. This publication addresses preparations through December 31, 2025, that were not included in previous Federal Register notices, and it does not affect preparations that have been previously published.
DATES:
Comments must be submitted electronically or postmarked on or before May 19, 2026.
ADDRESSES:
Interested persons may file written comments on this order in accordance with 21 CFR 1308.23(e). The electronic Federal Docket Management System will not accept comments after 11:59 p.m. Eastern Time on the last day of the comment period. To ensure proper handling of comments, please reference “Docket No. DEA-372” on all correspondence, including any attachments.
- Electronic comments: The Drug Enforcement Administration (DEA) encourages that all comments be submitted through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or to attach a file for lengthier comments. Please go to http://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon completion of your submission, you will receive a Comment Tracking Number for your comment. Please be aware that submitted comments are not instantaneously available for public view on Regulations.gov. If you have received a comment tracking number, your comment has been successfully submitted and there is no need to resubmit the same comment.
- Paper comments: Paper comments that duplicate the electronic submission are not necessary and are discouraged. Should you wish to mail a comment in lieu of an electronic comment, it should be sent via regular or express mail to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152.
- Paperwork Reduction Act Comments: All comments concerning collections of information under the Paperwork Reduction Act must be submitted to the Office of Information and Regulatory Affairs, OMB, Attention: Desk Officer for DOJ, Washington, DC 20503. Please state that your comment refers to Docket No. DEA-1189.
FOR FURTHER INFORMATION CONTACT:
Terrence L. Boos, Ph.D., Diversion Control Division, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (571) 362-8201.
SUPPLEMENTARY INFORMATION:
Posting of Public Comments
Please note that all comments received in response to this docket are considered part of the public record. The Drug Enforcement Administration (DEA) will make comments available for public inspection online at http://www.regulations.gov. Such information includes personal or business identifiers (such as name, address, state or Federal identifiers, etc.) voluntarily submitted by the commenter. Generally, all information voluntarily submitted by the commenter, unless clearly marked as Confidential Information in the method described below, will be publicly posted. Comments may be submitted anonymously. The Freedom of Information Act applies to all comments received.
Commenters submitting comments which include personal identifying information (PII), confidential, or proprietary business information that the commenter does not want made publicly available should submit two copies of the comment. One copy must be marked “CONTAINS CONFIDENTIAL INFORMATION” and should clearly identify all PII or business information the commenter does not want to be made publicly available, including any supplemental materials. DEA will review this copy, including the claimed PII and confidential business information, in its consideration of comments. The second copy should be marked “TO BE PUBLICLY POSTED” and must have all claimed confidential PII and business information already redacted. DEA will post only the redacted comment on http://www.regulations.gov for public inspection.
For easy reference, an electronic copy of this document and supplemental information to this proposed scheduling ( printed page 13611) action are available at http://www.regulations.gov.
Legal Authority
Section 201 of the Controlled Substances Act (CSA) (21 U.S.C. 811) authorizes the Attorney General, by regulation, to exempt from certain provisions of the CSA certain compounds, mixtures, or preparations containing a controlled substance, if she finds that such compounds, mixtures, or preparations meet the requirements detailed in 21 U.S.C. 811(g)(3)(B). [1 ] DEA regulations at 21 CFR 1308.23 and 1308.24 further detail the criteria by which the DEA Assistant Administrator may exempt a chemical preparation or mixture from certain provisions of the CSA. The Assistant Administrator may, pursuant to 21 CFR 1308.23(f), modify or revoke the criteria by which exemptions are granted and modify the scope of exemptions at any time.
Exempt Chemical Preparation Applications Submitted Between September 1, 2024, and December 31, 2025
DEA received applications between September 1, 2024, and December 31, 2025, requesting exempt chemical preparation status detailed in 21 CFR 1308.23. This publication addresses preparations through December 31, 2025, that were not included in previous Federal Register notices, and it does not affect preparations that have been previously published. Pursuant to the criteria stated in 21 U.S.C. 811(g)(3)(B) and in 21 CFR 1308.23, the Assistant Administrator has found that each of the compounds, mixtures, and preparations described in Chart I below is intended for laboratory, industrial, educational, or special research purposes and not for general administration to a human being or animal and either: (1) contains no narcotic controlled substance and is packaged in such a form or concentration that the packaged quantity does not present any significant potential for abuse; or (2) contains either a narcotic or non-narcotic controlled substance and one or more adulterating or denaturing agents in such a manner, combination, quantity, proportion, or concentration that the preparation or mixture does not present any potential for abuse and, if the preparation or mixture contains a narcotic controlled substance, is formulated in such a manner that it incorporates methods of denaturing or other means so that the preparation or mixture is not liable to be abused or have ill effects, if abused, and so that the narcotic substance cannot in practice be removed.
Accordingly, pursuant to 21 U.S.C. 811(g)(3)(B), 21 CFR 1308.23, and 21 CFR 1308.24, the Assistant Administrator has determined that each of the chemical preparations or mixtures generally described in Chart I below and specifically described in the application materials received by DEA is exempt, to the extent described in 21 CFR 1308.24, from application of sections 302, 303, 305, 306, 307, 308, 309, 1002, 1003, and 1004 (21 U.S.C. 822-823, 825-829, and 952-954) of the CSA, and 21 CFR 1301.74, as of the date that was provided in the approval letters to the individual requesters.
Scope of Approval
The exemptions are applicable only to the precise preparation or mixture described in the application submitted to DEA in the form(s) listed in this order and only for those above-mentioned sections of the CSA and the CFR. In accordance with 21 CFR 1308.24(h), any change in the quantitative or qualitative composition of the preparation or mixture, or change in the trade name or other designation of the preparation or mixture after the date of application requires a new application. The requirements set forth in 21 CFR 1308.24(b)-(e) apply to the exempted materials. In accordance with 21 CFR 1308.24(g), DEA may prescribe requirements other than those set forth in 21 CFR 1308.24(b)-(e) on a case-by-case basis for materials exempted in bulk quantities. Accordingly, in order to limit opportunities for diversion from the larger bulk quantities, DEA has determined that each of the exempted bulk products listed in this order may only be used in-house by the manufacturer, and may not be distributed for any purpose, or transported to other facilities.
Additional exempt chemical preparation requests received between September 1, 2024, and December 31, 2025, and not otherwise referenced in this order or in prior orders, may remain under consideration until DEA receives additional information required, pursuant to 21 CFR 1308.23(d), as detailed in separate correspondence to individual requesters. DEA's order on such requests will be communicated to the public in a future Federal Register publication.
DEA also notes that these exemptions are limited to exemption from only those sections of the CSA and the CFR that are specifically identified in 21 CFR 1308.24(a). All other requirements of the CSA and the CFR apply, including registration as an importer as required by 21 U.S.C. 957.
| Supplier name | Product name | Form | Application date |
| --- | --- | --- | --- |
| Absolute Standards, Inc | Amobarbital, 100 ug/mL, in Methanol | Glass ampoule: 1 ml | 10/15/2025 |
| Absolute Standards, Inc | Butabarbital, 100 ug/mL, in Methanol | Glass ampoule: 1 ml | 10/15/2025 |
| Absolute Standards, Inc | Carisoprodol PT, 1-1000 ug/mL, in Methanol | Glass ampoule: 1 ml | 10/15/2025 |
| Absolute Standards, Inc | Ethylmorphine, 100 ug/mL, in Methanol | Glass ampoule: 1 ml | 10/15/2025 |
| Absolute Standards, Inc | Hexobarbital, 100 ug/mL, in Methanol | Glass ampoule: 1 ml | 10/15/2025 |
| Absolute Standards, Inc | Lysergic acid diethylamide (LSD) PT, 1-50 ug/mL, in Acetonitrile | Glass ampoule: 1 ml | 10/15/2025 |
| Absolute Standards, Inc | Lysergic acid diethylamide-D3 (LSD-D3) PT, 1-50 ug/mL, in Acetonitrile | Glass ampoule: 1 ml | 10/15/2025 |
| Absolute Standards, Inc | Meprobamate PT, 1-1000 ug/mL, in Methanol | Glass ampoule: 1 ml | 10/15/2025 |
| Absolute Standards, Inc | Methcathinone PT, 1-1000 ug/mL, in Acetonitrile | Glass ampoule: 1 ml | 10/15/2025 |
| Absolute Standards, Inc | Methylphenidate, 100 ug/mL, in Methanol | Glass ampoule: 1 ml | 10/15/2025 |
| Absolute Standards, Inc | Norbuprenorphine-D3, 100 ug/mL, in Methanol | Glass ampoule: 1 ml | 10/15/2025 |
| Accriva Diagnostics, Inc | DirectCHECK Whole Blood Control Catalog: DCGACT-1 | 15 Glass ampoules: 0.5 mL each | 4/1/2025 |
| Accriva Diagnostics, Inc | DirectCHECK Whole Blood Control Catalog: DCGACT-2 | 15 Glass ampoules: 0.5 mL each | 4/1/2025 |
| Accriva Diagnostics, Inc | DirectCHECK Whole Blood Control Catalog: DCGLR-1 | 15 Glass ampoules: 0.5 mL each | 4/1/2025 |
| ( printed page 13612) | | | |
| Accriva Diagnostics, Inc | DirectCHECK Whole Blood Control Catalog: DCGLR-2 | 15 Glass ampoules: 0.5 mL each | 4/1/2025 |
| Accriva Diagnostics, Inc | DirectCHECK Whole Blood Control Catalog: DCJACT-A | 15 Glass ampoules: 0.5 mL each | 4/1/2025 |
| Accriva Diagnostics, Inc | DirectCHECK Whole Blood Control Catalog: DCJACT-N | 15 Glass ampoules: 0.5 mL each | 4/1/2025 |
| Accriva Diagnostics, Inc | DirectCHECK Whole Blood Control Catalog: DCJAPTT-A | 15 Glass ampoules: 0.5 mL each | 4/1/2025 |
| Accriva Diagnostics, Inc | DirectCHECK Whole Blood Control Catalog: DCJAPTT-N | 15 Glass ampoules: 0.5 mL each | 4/1/2025 |
| Accriva Diagnostics, Inc | DirectCHECK Whole Blood Control Catalog: DCJCAPTT-A | 15 Glass ampoules: 0.5 mL each | 4/1/2025 |
| Accriva Diagnostics, Inc | DirectCHECK Whole Blood Control Catalog: DCJCPT-A | 15 Glass ampoules: 0.5 mL each | 4/1/2025 |
| Accriva Diagnostics, Inc | DirectCHECK Whole Blood Control Catalog: DCJCPT-N | 15 Glass ampoules: 0.5 mL each | 4/1/2025 |
| Accriva Diagnostics, Inc | DirectCHECK Whole Blood Control Catalog: DCJLR-A | 15 Glass ampoules: 0.5 mL each | 4/1/2025 |
| Accriva Diagnostics, Inc | DirectCHECK Whole Blood Control Catalog: DCJLR-N | 15 Glass ampoules: 0.5 mL each | 4/1/2025 |
| Accriva Diagnostics, Inc | DirectCHECK Whole Blood Control Catalog: DCJPT-A | 15 Glass ampoules: 0.5 mL each | 4/1/2025 |
| Accriva Diagnostics, Inc | DirectCHECK Whole Blood Control Catalog: DCJPT-N | 15 Glass ampoules: 0.5 mL each | 4/1/2025 |
| Alfa Wassermann Diagnostic Technologies, LLC | T4 Antibody/Substrate Reagent | HDPE Ntrl Bottle: 12 mL | 4/8/2025 |
| American Proficiency Institute | Whole Blood Control for Proficiency Testing Catalog: HCA | 250-750 Glass ampoules: 0.5 mL each | 7/8/2025 |
| American Proficiency Institute | Whole Blood Control for Proficiency Testing Catalog: HCP | 250-750 Glass ampoules: 0.5 mL each | 7/8/2025 |
| American Proficiency Institute | Whole Blood Control for Proficiency Testing Catalog: HJP | 250-750 Glass ampoules: 0.5 mL each | 7/8/2025 |
| American Proficiency Institute | Whole Blood Control for Proficiency Testing Catalog: HLR | 250-750 Glass ampoules: 0.5 mL each | 7/8/2025 |
| American Proficiency Institute | Whole Blood Control for Proficiency Testing Catalog: HPL | 250-750 Glass ampoules: 0.5 mL each | 7/8/2025 |
| ARK Diagnostics, Inc | ARK TM Ketamine II Calibrator (Kit Reference Number 5083-0002-00) | Kit: 5 Dropper Vials, 10 mL each | 5/1/2025 |
| ARK Diagnostics, Inc | ARK TM Ketamine II Calibrator B (Cutoff) (Kit Reference Number 5083-0002-02) | Kit: 2 Dropper Vials, 10 mL each | 5/1/2025 |
| ARK Diagnostics, Inc | ARK TM Ketamine II Calibrator B (Cutoff), Forensic (Kit Reference Number 5083-0005-02) | Kit: 2 Dropper Vials, 10 mL each | 5/1/2025 |
| ARK Diagnostics, Inc | ARK TM Ketamine II Calibrator C (Cutoff) (Kit Reference Number 5083-0002-03) | Kit: 2 Dropper Vials, 10 mL each | 5/1/2025 |
| ARK Diagnostics, Inc | ARK TM Ketamine II Calibrator C (Cutoff), Forensic (Kit Reference Number 5083-0005-03) | Kit: 2 Dropper Vials, 10 mL each | 5/1/2025 |
| ARK Diagnostics, Inc | ARK TM Ketamine II Calibrator, Forensic (Kit Reference Number 5083-0005-00) | Kit: 5 Dropper Vials, 10 mL each | 5/1/2025 |
| ARK Diagnostics, Inc | ARK TM Ketamine II Control (Kit Reference Number 5083-0003-00) | Kit: 4 Dropper Vials, 10 mL each | 5/1/2025 |
| ARK Diagnostics, Inc | ARK TM Ketamine II Control (Kit Reference Number 5083-0003-01) | Kit: 4 Dropper Vials, 10 mL each | 5/1/2025 |
| ARK Diagnostics, Inc | ARK TM Ketamine II Control, Forensic (Kit Reference Number 5083-0006-00) | Kit: 4 Dropper Vials, 10 mL each | 5/1/2025 |
| ARK Diagnostics, Inc | ARK TM Ketamine II Control, Forensic (Kit Reference Number 5083-0006-01) | Kit: 4 Dropper Vials, 10 mL each | 5/1/2025 |
| Audit MicroControls, Inc | Control FD Assayed Chemistry Level 1 | Glass Vial: 5.0 mL | 5/12/2025 |
| Audit MicroControls, Inc | Control FD Assayed Chemistry Level 1 | Kit: 10 glass vials, 5 mL each | 5/12/2025 |
| Audit MicroControls, Inc | Control FD Assayed Chemistry Level 2 | Glass Vial: 5.0 mL | 5/12/2025 |
| Audit MicroControls, Inc | Control FD Assayed Chemistry Level 2 | Kit: 10 glass vials, 5 mL each | 5/12/2025 |
| Audit MicroControls, Inc | Control FD Assayed Chemistry Level 3 | Glass Vial: 5.0 mL | 5/12/2025 |
| Audit MicroControls, Inc | Control FD Assayed Chemistry Level 3 | Kit: 10 glass vials, 5 mL each | 5/12/2025 |
| Audit MicroControls, Inc | Linearity FD Immunoassay for Ortho Vitros Kit | Kit: 5 vials, 5 mL each | 9/8/2025 |
| Audit MicroControls, Inc | Linearity FD Immunoassay for Ortho Vitros Set 1 Level A | Vial: 5 mL | 9/8/2025 |
| Audit MicroControls, Inc | Linearity FD Immunoassay for Ortho Vitros Set 1 Level B | Vial: 5 mL | 9/8/2025 |
| Audit MicroControls, Inc | Linearity FD Immunoassay for Ortho Vitros Set 1 Level C | Vial: 5 mL | 9/8/2025 |
| Audit MicroControls, Inc | Linearity FD Immunoassay for Ortho Vitros Set 1 Level D | Vial: 5 mL | 9/8/2025 |
| Audit MicroControls, Inc | Linearity FD Immunoassay for Ortho Vitros Set 1 Level E | Vial: 5 mL | 9/8/2025 |
| Cayman Chemical Company | (±)-9-nor-9β-hydroxy Hexahydrocannabinol (exempt preparation) | Glass ampule: 1.0 mL | 4/29/2025 |
| Cayman Chemical Company | (±)-9-nor-9β-hydroxy Hexahydrocannabinol (exempt preparation) (100 µg/ml Acetonitrile) | Glass vial: 1.0 | 8/13/2025 |
| Cayman Chemical Company | (±)-9α-hydroxy Hexahydrocannabinol (exempt preparation) | Glass ampule: 1.0 mL | 4/29/2025 |
| Cayman Chemical Company | (±)-9α-hydroxy Hexahydrocannabinol (exempt preparation) (100 µg/ml Acetonitrile) | Glass vial: 1.0 | 8/13/2025 |
| Cayman Chemical Company | (6aR,9R)-Delta-10-Tetrahydrocannabinol Solution 1 mg/mL in Acetonitrile | Glass ampule: 1 mL | 7/1/2025 |
| ( printed page 13613) | | | |
| Cayman Chemical Company | 1 mg of 2-methylmethcathinone (hydrochloride),1 mg of 3-methylmethcathinone (hydrochloride), and 1 mg of mephedrone (hydrochloride) in 1 mL of methanol | Glass ampule: 1 mL | 10/1/2025 |
| Cayman Chemical Company | 1 mg of Δ8-THC-C9 in 1 mL of acetonitrile | Glass ampule: 1 mL | 10/1/2025 |
| Cayman Chemical Company | 1 mg of Δ9-THCA-B in 1 mL of acetonitrile | Glass ampule: 1 mL | 10/1/2025 |
| Cayman Chemical Company | 1 mg of Δ9-THCA-B in 1 mL of methanol | Glass ampule: 1 mL | 10/1/2025 |
| Cayman Chemical Company | 1 mg of Δ9-THCB butanoate in 1 mL of acetonitrile | Glass ampule: 1 mL | 10/1/2025 |
| Cayman Chemical Company | 1 mg of Δ9-THC-C9 in 1 mL acetonitrile | Glass ampule: 1 mL | 10/1/2025 |
| Cayman Chemical Company | 10(S)-hydroxy-9(R)-Hexahydrocannabinol (exempt preparation) | Glass ampule: 1.0 mL | 4/29/2025 |
| Cayman Chemical Company | 10(S)-hydroxy-9(R)-Hexahydrocannabinol (exempt preparation) (100 µg/ml Acetonitrile) | Glass vial: 1.0 | 8/13/2025 |
| Cayman Chemical Company | 100 Mg of 2-methylmethcathinone (hydrochloride), 100 Mg of 3-methylmethcathinone (hydrochloride), and 100 Mg of mephedrone (hydrochloride) in 1 mL of methanol | Glass ampule: 1 mL | 10/1/2025 |
| Cayman Chemical Company | 100 ug of Δ9-THCA-B in 1 mL of acetonitrile | Glass ampule: 1 mL | 10/1/2025 |
| Cayman Chemical Company | 100 ug of Δ9-THCA-B in 1 mL of methanol | Glass ampule: 1 mL | 10/1/2025 |
| Cayman Chemical Company | 11-hydroxy-9(R)-Hexahydrocannabinol (exempt preparation) | Glass ampule: 1.0 mL | 4/29/2025 |
| Cayman Chemical Company | 11-hydroxy-9(R)-Hexahydrocannabinol (exempt preparation) (100 µg/ml Acetonitrile) | Glass vial: 1.0 | 8/13/2025 |
| Cayman Chemical Company | 11-hydroxy-9(S)-Hexahydrocannabinol (exempt preparation) | Glass ampule: 1.0 mL | 4/29/2025 |
| Cayman Chemical Company | 11-hydroxy-9(S)-Hexahydrocannabinol (exempt preparation) (100 µg/ml Acetonitrile) | Glass vial: 1.0 | 8/13/2025 |
| Cayman Chemical Company | 8α,9α-epoxy Hexahydrocannabinol (exempt preparation) | Glass ampule: 1.0 mL | 4/29/2025 |
| Cayman Chemical Company | 8α,9α-epoxy Hexahydrocannabinol (exempt preparation) (100 µg/ml Acetonitrile) | Glass vial: 1.0 | 8/13/2025 |
| Cayman Chemical Company | 8β,9β-epoxy Hexahydrocannabinol (exempt preparation) | Glass ampule: 1.0 mL | 4/29/2025 |
| Cayman Chemical Company | 8β,9β-epoxy Hexahydrocannabinol (exempt preparation) (100 µg/ml Acetonitrile) | Glass vial: 1.0 | 8/13/2025 |
| Cayman Chemical Company | 9(R)-Hexahydrocannabinol (CRM) | Glass ampule: 1.0 mL | 4/29/2025 |
| Cayman Chemical Company | 9(R)-Hexahydrocannabinol methyl ether (exempt preparation) | Glass ampule: 1.0 mL | 4/29/2025 |
| Cayman Chemical Company | 9(R)-Hexahydrocannabinol-d9 (exempt preparation) | Glass ampule: 1.0 mL | 4/29/2025 |
| Cayman Chemical Company | 9(R)-Hexahydrocannabinol-d9 (exempt preparation) (100 µg/ml Acetonitrile) | Glass vial: 1.0 | 8/13/2025 |
| Cayman Chemical Company | 9(R)-Hexahydrocannabiphorol (exempt preparation) | Glass ampule: 1.0 mL | 4/29/2025 |
| Cayman Chemical Company | 9(R)-Hexahydrocannabiphorol methyl ether (exempt preparation) | Glass ampule: 1.0 mL | 4/29/2025 |
| Cayman Chemical Company | 9(S)-Hexahydrocannabinol (CRM) | Glass ampule: 1.0 mL | 4/29/2025 |
| Cayman Chemical Company | 9(S)-Hexahydrocannabinol-d9 (exempt preparation) | Glass ampule: 1.0 mL | 4/29/2025 |
| Cayman Chemical Company | 9(S)-Hexahydrocannabinol-d9 (exempt preparation) (100 µg/ml Acetonitrile) | Glass vial: 1.0 | 8/13/2025 |
| Cayman Chemical Company | 9(S)-Hexahydrocannabiphorol (exempt preparation) | Glass ampule: 1.0 mL | 4/29/2025 |
| Cayman Chemical Company | 9(S)-Hexahydrocannabiphorol methyl ether (exempt preparation) | Glass ampule: 1.0 mL | 4/29/2025 |
| Cayman Chemical Company | 9R-Hexahydrocannabinol Solution 1 mg/mL in Acetonitrile | Glass ampule: 1 mL | 7/1/2025 |
| Cayman Chemical Company | 9α,10α-Epoxyhexahydrocannabinol (exempt preparation) | Glass ampule: 1.0 mL | 4/29/2025 |
| Cayman Chemical Company | 9α,10α-Epoxyhexahydrocannabinol (exempt preparation) (100 µg/ml Acetonitrile) | Glass vial: 1.0 | 8/13/2025 |
| Cayman Chemical Company | 9β,10β-epoxy Hexahydrocannabinol (exempt preparation) | Glass ampule: 1.0 mL | 4/29/2025 |
| Cayman Chemical Company | 9β,10β-epoxy Hexahydrocannabinol (exempt preparation) (100 µg/ml Acetonitrile) | Glass vial: 1.0 | 8/13/2025 |
| Cayman Chemical Company | Alprazolam (CRM) 1 mg/mL in methanol | Glass Ampule: 0.5 mL | 12/9/2025 |
| Cayman Chemical Company | Alprazolam (CRM) 500 µg/mL in methanol | Glass Ampule: 1 mL | 12/9/2025 |
| Cayman Chemical Company | Clonazepam (CRM) 1 mg/mL in acetonitrile | Glass Ampule: 0.5 mL | 12/9/2025 |
| Cayman Chemical Company | Clonazepam (CRM) 500 µg/mL in acetonitrile | Glass Ampule: 1 mL | 12/9/2025 |
| Cayman Chemical Company | Delta-8-Tetrahydrocannabinol Solution 1 mg/mL in Methanol | Glass ampule: 1 mL | 7/1/2025 |
| Cayman Chemical Company | Delta-9 Tetrahydrocannabivarinic Acid Solution 1 mg/mL in Acetonitrile | Glass ampule: 1 mL | 7/1/2025 |
| Cayman Chemical Company | Delta-9-Tetrahydrocannabinolic Acid Solution 1 mg/mL in Acetonitrile | Glass ampule: 1 mL | 7/1/2025 |
| Cayman Chemical Company | Delta-9-Tetrahydrocannabinon Solution 1 mg/mL in Methanol | Glass ampule: 1 mL | 7/1/2025 |
| Cayman Chemical Company | exo-Tetrahydrocannabivarin methyl ether (exempt preparation), 1 mg/ml in acetonitrile | Glass vial: 1.0 mL | 4/7/2025 |
| Cayman Chemical Company | exo-Tetrahydrocannabivarin methyl ether (exempt preparation), 100 μg/ml in acetonitrile | Glass vial: 1.0 mL | 4/7/2025 |
| Cayman Chemical Company | exo-THC methyl ether (exempt preparation), 1 mg/ml in acetonitrile | Glass vial: 1.0 mL | 4/7/2025 |
| Cayman Chemical Company | exo-THC methyl ether (exempt preparation), 100 μg/ml in acetonitrile | Glass vial: 1.0 mL | 4/7/2025 |
| Cayman Chemical Company | exo-THCP methyl ether (exempt preparation), 1 mg/ml in acetonitrile | Glass vial: 1.0 mL | 4/7/2025 |
| Cayman Chemical Company | exo-THCP methyl ether (exempt preparation), 100 μg/ml in acetonitrile | Glass vial: 1.0 mL | 4/7/2025 |
| Cayman Chemical Company | Lormetazepam (CRM), 1 mg/mL in methanol | Glass ampule: 1.0 mL | 9/23/2025 |
| Cayman Chemical Company | meta-Fluorofentanyl-d5 (hydrochloride) (exempt preparation) 100 μg/mL in methanol | Glass vial: 1.0 mL | 4/18/2025 |
| Cayman Chemical Company | meta-methyl Acetyl fentanyl (hydrochloride) (exempt preparation) 100 μg/mL in methanol | Glass vial: 1.0 mL | 4/18/2025 |
| Cayman Chemical Company | meta-Methylfentanyl-d5 (hydrochloride) (exempt preparation) 100 μg/mL in methanol | Glass vial: 1.0 mL | 4/18/2025 |
| Cayman Chemical Company | ortho-Fluorofentanyl-d5 (hydrochloride) (exempt preparation) 100 μg/mL in methanol | Glass vial: 1.0 mL | 4/18/2025 |
| Cayman Chemical Company | ortho-methyl Acetyl fentanyl (hydrochloride) (exempt preparation) 100 μg/mL in methanol | Glass vial: 1.0 mL | 4/18/2025 |
| Cayman Chemical Company | para-methyl Acetyl fentanyl (hydrochloride) (exempt preparation) 100 μg/mL in methanol | Glass vial: 1.0 mL | 4/18/2025 |
| Cayman Chemical Company | para-Methylfentanyl-d5 (hydrochloride) (exempt preparation) 100 μg/mL in methanol | Glass vial: 1.0 mL | 4/18/2025 |
| Cayman Chemical Company | Phytocannabinoid Acids Mixture 6 Solution 1 mg/mL in 99:1 acetonitrile/DIPEA stabilized with 0.05% ascorbic acid | Glass ampule: 1 mL | 7/1/2025 |
| ( printed page 13614) | | | |
| Cayman Chemical Company | Phytocannabinoid Neutrals Mixture 8 Solution 1 mg/mL in Acetonitrile | Glass ampule: 1 mL | 7/1/2025 |
| Cayman Chemical Company | Protonitazene-d7 (CRM) (100 µg/ml Methanol) | Glass vial: 1.0 | 8/13/2025 |
| Cayman Chemical Company | Tetrahydrocannabivarin Solution 1 mg/mL in Methanol | Glass ampule: 1 mL | 7/1/2025 |
| Cayman Chemical Company | α'-hydroxy Fentanyl (exempt preparation) (100 µg/ml Methanol) | Glass vial: 1.0 | 8/13/2025 |
| Cayman Chemical Company | α-Pyrrolidinoisohexanophenone-d8 (hydrochloride) (CRM) (100 µg/ml Methanol) | Glass vial: 1.0 | 8/13/2025 |
| Cayman Chemical Company | Δ8-THC methyl ether (exempt preparation), 1 mg/ml in acetonitrile | Glass vial: 1.0 mL | 4/7/2025 |
| Cayman Chemical Company | Δ8-THC-methylcarbonate (exempt preparation), 1 mg/ml in acetonitrile | Glass vial: 1.0 mL | 4/7/2025 |
| Cayman Chemical Company | Δ8-THCP-d3 (exempt preparation) (1 mg/ml Acetonitrile) | Glass vial: 1.0 | 8/13/2025 |
| Cayman Chemical Company | Δ8-THCP-d3 (exempt preparation) (100 µg/ml Acetonitrile) | Glass vial: 1.0 | 8/13/2025 |
| Cayman Chemical Company | Δ9-THC methyl ether (exempt preparation), 1 mg/ml in 99:1 CAN:DIPEA | Glass vial: 1.0 mL | 4/7/2025 |
| Cayman Chemical Company | Δ9-THC methyl ether (exempt preparation), 1 mg/ml in acetonitrile | Glass vial: 1.0 mL | 4/7/2025 |
| Cayman Chemical Company | Δ9-THC methyl ether (exempt preparation), 1 mg/ml in methanol | Glass vial: 1.0 mL | 4/7/2025 |
| Cayman Chemical Company | Δ9-THC methyl ether (exempt preparation), 100 μg/ml in 99:1 CAN:DIPEA | Glass vial: 1.0 mL | 4/7/2025 |
| Cayman Chemical Company | Δ9-THC-methylcarbonate (exempt preparation), 1 mg/ml in 99:1 CAN:DIPEA | Glass vial: 1.0 mL | 4/7/2025 |
| Cayman Chemical Company | Δ9-THC-methylcarbonate (exempt preparation), 1 mg/ml in acetonitrile | Glass vial: 1.0 mL | 4/7/2025 |
| Cayman Chemical Company | Δ9-THC-methylcarbonate (exempt preparation), 100 μg/ml in 99:1 CAN:DIPEA | Glass vial: 1.0 mL | 4/7/2025 |
| Cayman Chemical Company | Δ9-THC-methylcarbonate (exempt preparation), 100 μg/ml in acetonitrile | Glass vial: 1.0 mL | 4/7/2025 |
| Cayman Chemical Company | Δ9-THCP-d3 (exempt preparation) (1 mg/ml Acetonitrile) | Glass vial: 1.0 | 8/13/2025 |
| Cayman Chemical Company | Δ9-THCP-d3 (exempt preparation) (100 µg/ml Acetonitrile) | Glass vial: 1.0 | 8/13/2025 |
| Cerilliant Corporation | 3'-fluoro ortho-Fluorofentanyl HCl: 0.1 mg/mL in 0.5 mL solvent | Glass Ampule: 0.5 ml | 8/13/2025 |
| Cerilliant Corporation | 3'-Fluorofentanyl HCl: 0.1 mg/mL in 0.5 mL solvent | Glass Ampule: 0.5 ml | 8/13/2025 |
| Cerilliant Corporation | 4-Chloromethcathionone HCl (4-CMC HCl) | Glass ampule: 1 mL | 12/17/2025 |
| Cerilliant Corporation | Brivaracetam: 1.0 mg/mL in 1 mL solvent | Glass Ampule: 1 ml | 8/13/2025 |
| Cerilliant Corporation | Cannabinoid Mixture (Neutrals) 8 Component Solution HC: 1.0 mg/mL in 0.5 mL Solvent | Glass Ampule: 0.5 ml | 8/13/2025 |
| Cerilliant Corporation | Cannabinoid Mixture (Acids) 6 Component Solution HC: 1.0 mg/mL in 0.5 mL Solvent | Glass Ampule: 0.5 ml | 8/13/2025 |
| Cerilliant Corporation | FEN Validation Sample Set 1 | Set: 3 tubes, 10 ml each | 7/18/2025 |
| Cerilliant Corporation | FEN Validation Sample Set 2 | Set: 9 tubes, 10 ml each | 7/18/2025 |
| Cerilliant Corporation | FEN Validation Sample Set 3 | Set: 4 tubes, 30 ml each | 7/18/2025 |
| Cerilliant Corporation | FEN Validation Sample Set 4 | Set: 2 tubes,10 ml each | 7/18/2025 |
| Cerilliant Corporation | FEN Validation Sample Set 5 | Set: 52 vials, 1 ml each | 7/18/2025 |
| Cerilliant Corporation | LC-ABZ & ABZ+BT Mix#2&3 | Glass ampule: 1 mL | 11/6/2025 |
| Cerilliant Corporation | meta-Fluoro acrylfetanyl HCl: 0.1 mg/mL in 1 mL solvent | Glass Ampule: 1 ml | 8/13/2025 |
| Cerilliant Corporation | Phenmetrazine HCl: 0.1 mg/mL in solvent | Glass Ampule: 1 ml | 8/13/2025 |
| CFSAA—RTI International | 12198-102-8 | Glass tube: 7 ml | 7/30/2025 |
| CFSAA—RTI International | 12198-102-9 | Glass tube: 7 ml | 7/30/2025 |
| Chiron AS | (-)-trans-Δ9-THC (in methanol) | Glass ampule: 1 mL | 11/10/2025 |
| Chiron AS | (-)-trans-Δ9-THC-13C4 (pentyl-2,3,4,5-13C4) (in methanol) | Glass ampule: 1 mL | 11/10/2025 |
| Chiron AS | (-)-trans-Δ9-THC-d3 (pentyl-5,5,5-d3) (in methanol) | Glass ampule: 1 mL | 11/10/2025 |
| Chiron AS | (±)-MDA hydrochloride (in methanol) | Glass ampule: 1 mL | 11/10/2025 |
| Chiron AS | (±)-MDA-d5 hydrochloride (alpha-methyl-d3-ethylamine-1,2-d2) (in methanol) | Glass ampule: 1 mL | 11/10/2025 |
| Chiron AS | (±)-MDMA hydrochloride (in methanol) | Glass ampule: 1 mL | 11/10/2025 |
| Chiron AS | (±)-Methadone hydrochloride (in methanol) | Glass ampule: 1 mL | 11/10/2025 |
| Chiron AS | (±)-trans-11-Nor-9-carboxy-Δ9-THC-d3 (pentyl-5,5,5-d3) (in methanol) | Glass ampule: 1 mL | 11/10/2025 |
| Chiron AS | Benzoylecgonine (in methanol) | Glass ampule: 1 mL | 11/10/2025 |
| Chiron AS | Benzoylecgonine-d3 tetrahydrate (N-methyl-d3) (in methanol) | Glass ampule: 1 mL | 11/10/2025 |
| Chiron AS | Cocaine hydrochloride (in methanol) | Glass ampule: 1 mL | 11/10/2025 |
| Chiron AS | Codeine (free base) (in methanol) | Glass ampule: 1 mL | 11/10/2025 |
| Chiron AS | Dihydrocodeine-d6 hydrochloride (N-methyl-d3, methoxy-d3 (in methanol) | Glass ampule: 1 mL | 11/10/2025 |
| Chiron AS | DL-Amphetamine (free base) (in methanol) | Glass ampule: 1 mL | 11/10/2025 |
| Chiron AS | DL-Methamphetamine hydrochloride (in methanol) | Glass ampule: 1 mL | 11/10/2025 |
| Chiron AS | Morphine monohydrate (in methanol) | Glass ampule: 1 mL | 11/10/2025 |
| Chiron AS | Morphine-d3 hydrochloride (N-methyl-d3) (in methanol) | Glass ampule: 1 mL | 11/10/2025 |
| Chromsystems Instruments and Chemicals GmbH | 3PLUS1® Multilevel Plasma Calibrator Set (92025-XT2) | 4 Vials: 1 mL each | 7/8/2025 |
| Chromsystems Instruments and Chemicals GmbH | MassCheck® Antiepileptic Drugs XT2 Plasma Control Set Level 1 (0250-XT2) | 5 Vials: 1 mL each | 7/8/2025 |
| Chromsystems Instruments and Chemicals GmbH | MassCheck® Antiepileptic Drugs XT2 Plasma Control Set Level 2 (0251-XT2) | 5 Vials: 1 mL each | 7/8/2025 |
| Cliniqa Corporation | Multi Constituent Calibrator (MCC) Master Calibrator (or other Description) Level 1 | Bottle/vial: 5 mL—2 L | 4/30/2025 |
| Cliniqa Corporation | Multi Constituent Calibrator (MCC) Master Calibrator (or other Description) Level 2 | Bottle/vial: 5 mL—2 L | 4/30/2025 |
| Cliniqa Corporation | Multi Constituent Calibrator (MCC) Master Calibrator (or other Description) Level 3 | Bottle/vial: 5 mL—2 L | 4/30/2025 |
| Cliniqa Corporation | Multi Constituent Calibrator (MCC) Master Calibrator (or other Description) Level 4 | Bottle/vial: 5 mL—2 L | 4/30/2025 |
| Cliniqa Corporation | Multi Constituent Calibrator (MCC) Master Calibrator (or other Description) Level 5 | Bottle/vial: 5 mL—2 L | 4/30/2025 |
| Cliniqa Corporation | Multi Constituent Calibrator (MCC) Master Calibrator (or other Description) Level 6 | Bottle/vial: 5 mL—2 L | 4/30/2025 |
| ( printed page 13615) | | | |
| College of American Pathologists | Whole Blood Control for Proficiency Testing Catalog: CT2 | 250-750 Glass ampoules: 0.5 mL each | 7/8/2025 |
| College of American Pathologists | Whole Blood Control for Proficiency Testing Catalog: CT3 | 250-750 Glass ampoules: 0.5 mL each | 7/8/2025 |
| College of American Pathologists | Whole Blood Control for Proficiency Testing Catalog: CT3Q | 250-750 Glass ampoules: 0.5 mL each | 7/8/2025 |
| College of American Pathologists | Whole Blood Control for Proficiency Testing Catalog: POC15 | 250-750 Glass ampoules: 0.5 mL each | 7/8/2025 |
| College of American Pathologists | Whole Blood Control for Proficiency Testing Catalog: POC16 | 250-750 Glass ampoules: 0.5 mL each | 7/8/2025 |
| College of American Pathologists | Whole Blood Control for Proficiency Testing Catalog: WP4 | 250-750 Glass ampoules: 0.5 mL each | 7/8/2025 |
| College of American Pathologists | Whole Blood Control for Proficiency Testing Catalog: WP6 | 250-750 Glass ampoules: 0.5 mL each | 7/8/2025 |
| College of American Pathologists | Whole Blood Control for Proficiency Testing Catalog:CT2Q | 250-750 Glass ampoules: 0.5 mL each | 7/8/2025 |
| College of American Pathologists (CAP) | 2026 DMPM-01 | HDPE bottle: 40 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 DMPM-02 | HDPE bottle: 40 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 DMPM-03 | HDPE bottle: 40 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 DMPM-05 | HDPE bottle: 40 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 DMPM-06 | HDPE bottle: 40 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 DMPM-07 | HDPE bottle: 40 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 FTC-03 | HDPE bottle: 20 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 FTC-04 | HDPE bottle: 20 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 FTC-06 | HDPE bottle: 20 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 FTC-07 | HDPE bottle: 20 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 FTC-08 | HDPE bottle: 20 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 FTC-10 | HDPE bottle: 20 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 FTC-11 | HDPE bottle: 20 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 FTC-12 | HDPE bottle: 20 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 FTC-13 | HDPE bottle: 20 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 FTC-14 | HDPE bottle: 20 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 FTC-15 | HDPE bottle: 20 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 NOB-01 | Amber glass vial: 15 mL | 7/17/2025 |
| College of American Pathologists (CAP) | 2026 NOB-02 | Amber glass vial: 15 mL | 7/17/2025 |
| College of American Pathologists (CAP) | 2026 NOB-03 | Amber glass vial: 15 mL | 7/17/2025 |
| College of American Pathologists (CAP) | 2026 NOB-04 | Amber glass vial: 15 mL | 7/17/2025 |
| College of American Pathologists (CAP) | 2026 NOB-05 | Amber glass vial: 15 mL | 7/17/2025 |
| College of American Pathologists (CAP) | 2026 NOB-06 | Amber glass vial: 15 mL | 7/17/2025 |
| College of American Pathologists (CAP) | 2026 OFD-01 | HDPE vial: 2 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 OFD-02 | HDPE vial: 2 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 OFD-03 | HDPE vial: 2 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 OFD-04 | HDPE vial: 2 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 OFD-05 | HDPE vial: 2 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 OFD-06 | HDPE vial: 2 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 OFD-07 | HDPE vial: 2 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 OFD-08 | HDPE vial: 2 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 OFD-09 | HDPE vial: 2 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 OFD-10 | HDPE vial: 2 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 OFD-11 | HDPE vial: 2 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 OFD-12 | HDPE vial: 2 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 OFD-13 | HDPE vial: 2 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 OFD-14 | HDPE vial: 2 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 OFD-15 | HDPE vial: 2 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 OFD-16 | HDPE vial: 2 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 OFD-17 | HDPE vial: 2 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 OFD-18 | HDPE vial: 2 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 OFD-19 | HDPE vial: 2 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 OFD-20 | HDPE vial: 2 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 SCDD-01 | HDPE bottle: 10 mL | 7/17/2025 |
| College of American Pathologists (CAP) | 2026 SCDD-02 | HDPE bottle: 10 mL | 7/17/2025 |
| College of American Pathologists (CAP) | 2026 SCDD-03 | HDPE bottle: 10 mL | 7/17/2025 |
| College of American Pathologists (CAP) | 2026 SCDD-04 | HDPE bottle: 10 mL | 7/17/2025 |
| College of American Pathologists (CAP) | 2026 SCDD-06 | HDPE bottle: 10 mL | 7/17/2025 |
| College of American Pathologists (CAP) | 2026 T-01 | HDPE bottle: 20 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 T-02 | HDPE bottle: 20 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 T-03 | HDPE bottle: 20 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 T-07 | HDPE bottle: 20 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 T-09 | HDPE bottle: 20 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 T-10 | HDPE bottle: 50 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 T-12 | HDPE bottle: 20 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 T-14 | HDPE bottle: 20 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 T-15 | HDPE bottle: 50 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 THCB-01 | Glass vial: 10 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 THCB-02 | Glass vial: 10 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 THCB-03 | Glass vial: 10 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 THCB-04 | Glass vial: 10 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 THCB-05 | Glass vial: 10 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 THCB-06 | Glass vial: 10 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 UDS-01 | HDPE bottle: 10 ml | 7/29/2025 |
| ( printed page 13616) | | | |
| College of American Pathologists (CAP) | 2026 UDS-02 | HDPE bottle: 10 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 UDS-03 | HDPE bottle: 10 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 UDS-04 | HDPE bottle: 10 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 UDS-05 | HDPE bottle: 10 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 UDS-06 | HDPE bottle: 10 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 UDS-07 | HDPE bottle: 10 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 UDS-08 | HDPE bottle: 10 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 UDS-09 | HDPE bottle: 10 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 UDS-10 | HDPE bottle: 10 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 UDS-11 | HDPE bottle: 10 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 UDS-12 | HDPE bottle: 10 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 UDS-13 | HDPE bottle: 10 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 UDS-14 | HDPE bottle: 10 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 UDS-15 | HDPE bottle: 10 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 UT-01 | HDPE bottle: 50 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 UT-02 | HDPE bottle: 50 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 UT-05 | HDPE bottle: 50 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 UT-06 | HDPE bottle: 50 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 UT-07 | HDPE bottle: 50 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 UT-09 | HDPE bottle: 50 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 UT-11 | HDPE bottle: 50 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 UT-12 | HDPE bottle: 50 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 UT-13 | HDPE bottle: 50 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 UT-15 | HDPE bottle: 50 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 UTCO-01 | HDPE bottle: 40 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 ZE-01 | Glass vial: 5 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 ZE-02 | Glass vial: 5 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 ZE-03 | Glass vial: 5 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 ZE-04 | Glass vial: 5 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 ZE-05 | Glass vial: 5 ml | 7/29/2025 |
| College of American Pathologists (CAP) | 2026 ZE-06 | Glass vial: 5 ml | 7/29/2025 |
| Helena Laboratories | SPIFE Nexus Alkaline Phosphatase (ALP) Kit, Cat. No. 2345, 2346 | Kit: 10 gels | 4/29/2025 |
| LGC—Dr. Ehrenstorfer | Custom 1-Methylamino-1-(3,4-methylenedioxyphenyl)-propane Hydrochloride 10 ug/mL in Acetonitrile | Pack: 5 ampules, 1 mL each | 9/24/2025 |
| LGC—Dr. Ehrenstorfer | Custom 1-Methylamino-1-(3,4-methylenedioxyphenyl)-propane Hydrochloride 10 ug/mL in Acetonitrile Hydrochloride 10 ug/mL in Acetonitrile | Amber glass ampule: 1 mL | 9/24/2025 |
| LGC—Dr. Ehrenstorfer | Custom Pharmaceutical Mixture 5-17941 (100 ug/mL in Methanol) | Clamshell: 3 vials, 1 mL each | 9/12/2025 |
| LGC Clinical Diagnostics, Inc | Fertility 1 ab Bulk—Level 1 | Volumetric glassware: 8,000 mL | 9/5/2024 |
| LGC Clinical Diagnostics, Inc | Fertility 1 ab Bulk—Level 2 | Volumetric glassware: 8,000 mL | 9/5/2024 |
| LGC Clinical Diagnostics, Inc | Fertility 1 ab Bulk—Level 3 | Volumetric glassware: 8,000 mL | 9/5/2024 |
| LGC Clinical Diagnostics, Inc | Fertility 1 ab Bulk—Level 4 | Volumetric glassware: 8,000 mL | 9/5/2024 |
| LGC Clinical Diagnostics, Inc | Fertility 1 ab Bulk—Level 5 | Volumetric glassware: 8,000 mL | 9/5/2024 |
| LGC Clinical Diagnostics, Inc | Fertility 1 ab WrkBlk—Level 1 | Volumetric glassware: 200-20,000 mL | 9/5/2024 |
| LGC Clinical Diagnostics, Inc | Fertility 1 ab WrkBlk—Level 5 | Volumetric glassware: 200-20,000 mL | 9/5/2024 |
| LGC Clinical Diagnostics, Inc | Fertility 1 re Bulk—Level 1 | Volumetric glassware: 8,000 mL | 9/5/2024 |
| LGC Clinical Diagnostics, Inc | Fertility 1 re Bulk—Level 2 | Volumetric glassware: 8,000 mL | 9/5/2024 |
| LGC Clinical Diagnostics, Inc | Fertility 1 re Bulk—Level 3 | Volumetric glassware: 8,000 mL | 9/5/2024 |
| LGC Clinical Diagnostics, Inc | Fertility 1 re Bulk—Level 4 | Volumetric glassware: 8,000 mL | 9/5/2024 |
| LGC Clinical Diagnostics, Inc | Fertility 1 re Bulk—Level 5 | Volumetric glassware: 8,000 mL | 9/5/2024 |
| LGC Clinical Diagnostics, Inc | Fertility 1 re WrkBlk—Level 1 | Volumetric glassware: 200-20,000 mL | 9/5/2024 |
| LGC Clinical Diagnostics, Inc | Fertility 1 re WrkBlk—Level 5 | Volumetric glassware: 200-20,000 mL | 9/5/2024 |
| LGC Clinical Diagnostics, Inc | VALIDATE Fertility 1 Test Set 502ab | 5 Bottles: 3 mL each | 9/5/2024 |
| LGC Clinical Diagnostics, Inc | VALIDATE Fertility 1 Test Set 502re | 5 Bottles: 4 mL each | 9/5/2024 |
| LGC Clinical Diagnostics, Inc | VALIDATE LCMS Steroids 1003ro Bulk Level 1 | Plastic/Nalgene bottles or carboys: 3,600 mL | 10/24/2025 |
| LGC Clinical Diagnostics, Inc | VALIDATE LCMS Steroids 1003ro Bulk Level 2 | Plastic/Nalgene bottles or carboys: 3,600 mL | 10/24/2025 |
| LGC Clinical Diagnostics, Inc | VALIDATE LCMS Steroids 1003ro Bulk Level 3 | Plastic/Nalgene bottles or carboys: 3,600 mL | 10/24/2025 |
| LGC Clinical Diagnostics, Inc | VALIDATE LCMS Steroids 1003ro Bulk Level 4 | Plastic/Nalgene bottles or carboys: 3,600 mL | 10/24/2025 |
| LGC Clinical Diagnostics, Inc | VALIDATE LCMS Steroids 1003ro Bulk Level 5 | Plastic/Nalgene bottles or carboys: 3,600 mL | 10/24/2025 |
| LGC Clinical Diagnostics, Inc | VALIDATE LCMS Steroids 1003ro Working Bulk Level 1 | Plastic/Nalgene bottles or carboys: 9,000 mL | 10/24/2025 |
| ( printed page 13617) | | | |
| LGC Clinical Diagnostics, Inc | VALIDATE LCMS Steroids 1003ro Working Bulk Level 5 | Plastic/Nalgene bottles or carboys: 9,000 mL | 10/24/2025 |
| LGC Clinical Diagnostics, Inc | VALIDATE LCMS Steroids Level 1 | Plastic dropper bottle: 6 mL | 10/24/2025 |
| LGC Clinical Diagnostics, Inc | VALIDATE LCMS Steroids Level 2 | Plastic dropper bottle: 6 mL | 10/24/2025 |
| LGC Clinical Diagnostics, Inc | VALIDATE LCMS Steroids Level 3 | Plastic dropper bottle: 6 mL | 10/24/2025 |
| LGC Clinical Diagnostics, Inc | VALIDATE LCMS Steroids Level 4 | Plastic dropper bottle: 6 mL | 10/24/2025 |
| LGC Clinical Diagnostics, Inc | VALIDATE LCMS Steroids Level 5 | Plastic dropper bottle: 6 mL | 10/24/2025 |
| LGC Clinical Diagnostics, Inc | VALIDATE LCMS TDM1 Bulk Level 1 | Plastic/Nalgene bottles or carboys: 3,600 mL | 10/24/2025 |
| LGC Clinical Diagnostics, Inc | VALIDATE LCMS TDM1 Bulk Level 2 | Plastic/Nalgene bottles or carboys: 3,600 mL | 10/24/2025 |
| LGC Clinical Diagnostics, Inc | VALIDATE LCMS TDM1 Bulk Level 3 | Plastic/Nalgene bottles or carboys: 3,600 mL | 10/24/2025 |
| LGC Clinical Diagnostics, Inc | VALIDATE LCMS TDM1 Bulk Level 4 | Plastic/Nalgene bottles or carboys: 3,600 mL | 10/24/2025 |
| LGC Clinical Diagnostics, Inc | VALIDATE LCMS TDM1 Bulk Level 5 | Plastic/Nalgene bottles or carboys: 3,600 mL | 10/24/2025 |
| LGC Clinical Diagnostics, Inc | VALIDATE LCMS TDM1 Level 1 | Plastic dropper bottle: 6 mL | 10/24/2025 |
| LGC Clinical Diagnostics, Inc | VALIDATE LCMS TDM1 Level 2 | Plastic dropper bottle: 6 mL | 10/24/2025 |
| LGC Clinical Diagnostics, Inc | VALIDATE LCMS TDM1 Level 3 | Plastic dropper bottle: 6 mL | 10/24/2025 |
| LGC Clinical Diagnostics, Inc | VALIDATE LCMS TDM1 Level 4 | Plastic dropper bottle: 6 mL | 10/24/2025 |
| LGC Clinical Diagnostics, Inc | VALIDATE LCMS TDM1 Level 5 | Plastic dropper bottle: 6 mL | 10/24/2025 |
| LGC Clinical Diagnostics, Inc | VALIDATE LCMS TDM1 Working Bulk Level 1 | Plastic/Nalgene bottles or carboys: 9,000 mL | 10/24/2025 |
| LGC Standards | (-)-a-Acetylmethadol Hydrochloride (1.0mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | (-)-a-Methadol (1.0mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | (+)-19-Norandrost-4-ene-3,17-dione (1mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | (+)-Tramadol-d6 Hydrochloride (1.0mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | (R)-Ketamine Hydrochloride (1.0mg/ml in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | (S)-Ketamine Hydrochloride (1.0mg/ml in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | (S)-Ketamine-d6 Hydrochloride (1.0mg/ml in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | (S)-Methadone Hydrochloride (1.0mg/ml in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | 10-Oxo Naloxone (1.0mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | 17α-Methyl Testosterone (1.0 mg/mL in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | 2,3-Thioepoxy Madol (1.0mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | 3-O-(Codein-2-yl)morphine (1.0mg/ml in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | 4-Hydroxy Nandrolone (1.0mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | 4-Hydroxy Testosterone (1.0mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | 5a-Androstane-3a,17b-diol (1.0mg/ml in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | 5a-Dihydro Testosterone Undecanoate (1.0mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | 6-Acetyl Morphine (1.0mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | 6alpha-Oxycodol (1mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Allobarbital-d10 (1mg/ml in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Alphaprodine Hydrochloride (1.0 mg/mL in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Amineptine (1.0mg/ml in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Aminorex (1 mg/ml in Acetronitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Androstenedione-d3 (1.0 mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Anileridine (1.0 mg/mL in ethyl acetate) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Barbital-d5 (1.0mg/mL in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Boldenone Undecylenate (1.0mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Boldenone-d3 (1.0 mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Boldione (1.0mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Buprenorphine N-oxide (1.0mg/ml in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Butobarbital (1.0 mg/ml in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Chlordiazepoxide (1.0 mg/mL in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Clobazam-13C6 (1.0mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Clonitazene (1.0mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Clorazepate Dipotassium (1.0mg/ml in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Clostebol (1.0mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Clotiazepam (1 mg/mL in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Codeine (1.0 mg/mL in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Delorazepam (100 ug/mL in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Diazepam (1mg/mL in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Diethylpropion Hydrochloride (1.0 mg/mL in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Diethylpropion Hydrochloride (1mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Dihydrocodeine Phosphate (1.0mg/ml in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Diphenoxylate Hydrochloride (1.0mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | D-threo-Methylphenidate Hydrochloride (1.0mg/ml in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Ecgonidine Methyl Ester (1.0mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Ethyl Loflazepate (1.0mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Ethyl Morphine 6-b-D-Glucuronide (1.0mg/ml in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Fencamfamin Hydrochloride (1 mg/mL in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Fentanyl-d5 (100 ug/mL in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Fludiazepam (1 mg/mL in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Hydrocodone (1.0mg/mL in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Ketamine Hydrochloride (1.0 mg/mL in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | L-Cocaine (1.0 mg/ml in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Levorphanol L-Tartrate (1.0 mg/mL in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Loprazolam (100 ug/mL in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Lorazepam (1.0 mg/mL in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| ( printed page 13618) | | | |
| LGC Standards | MDPV Hydrochloride (1 mg/mL in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Mephedrone Hydrochloride (1.0 mg/mL in methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Mephedrone-d3 Hydrochloride (100ug/ml in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Meprobamate-d3 (100 ug/mL in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Methandrostenolone-d3 (1.0mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Methcathinone Hydrochloride (1.0 mg/mL in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Methyprylon (1.0 mg/mL in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Metribolone (1.0mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | m-Hydroxycocaine (1.0 mg/mL in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Midazolam (1.0 mg/mL in methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Midazolam-d6 (1.0 mg/mL in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Morphine (1.0mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Morphine 3-b-D-Glucuronide (1.0 mg/mL in Methanol w/0.05% NaOH) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Morphine 6-b-D-Glucuronide (1.0 mg/mL in Water:Methanol 80:20) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Morphine-d3 (100 μg/mL in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Nandrolone (1.0 mg/mL in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Nandrolone-d3 (1.0mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | N-Benzylpiperazine Dihydrochloride (1.0 mg/mL in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Norbolethone (1.0mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Norclostebol (1.0 mg/mL in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Nordazepam-d5 (1.0 mg/mL in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Norhydrocodone-D3.HCl, 1mg/ml in Methanol (as free base) | Glass ampule: 1 mL | 8/28/2025 |
| LGC Standards | Oxandrolone (1.0 mg/mL in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Oxazolam (1.0mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Oxycodone Hydrochloride (1.0mg/ml in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Oxycodone N-Oxide (1.0mg/ml in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Oxymesterone (1.0mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Oxymorphone (1.0 mg/mL in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Pentazocine (1mg/ml in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Phenobarbital (1.0mg/mL in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Phenobarbital-d5 (100μg/mL in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Pipradrol Hydrochloride (1.0 mg/mL in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Piritramide-d10 (1.0mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Psilocin (1.0 mg/mL in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Psilocin-d4 (1.0mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Psilocybin (1.0mg/ml in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Racemethorphan hydrobromide (1.0 mg/mL in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | S-(+)-Methamphetamine Hydrochloride (1.0mg/ml in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Stenbolone (1.0mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Synthetic Cannabinoid Mixture 1 (mixture of JWH 250, JWH 200, CP-47497, CP 47497C8 and HU 211, 100 ug/mL of each component in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Synthetic Cannabinoid Mixture 2 (mixture of AM2201, JWH 019, JWH 081, and JWH 122, 100 ug/mL of each component in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Synthetic Cannabinoid Mixture 3 (mixture of AM2233, JWH 015, JWH 203, and JWH 210, RCS-4, and RCS-8, 100 ug/mL of each component in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Tapentadol O-b-D-Glucuronide (1.0mg/ml in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Temazepam (1.0 mg/mL in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Tenamfetamine Hydrochloride (1.0mg/ml in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Testosterone (1.0mg/mL in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Testosterone 17-Decanoate (1.0mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Testosterone 17-O-Acetate-d3 (1mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Testosterone Cypionate-d3 (1.0mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Testosterone-2,2,4,6,6-d5 (1.0mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Testosterone-d3 (100 ug/mL in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Tetrahydrofuran Fentanyl (100 ug/mL in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Thebaine (1.0mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Thebaine-N-(methyl-d3) (1.0 mg/mL in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Thiopental-d5 (1.0mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Tilidine Hydrochloride (1.0 mg/mL in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Tilidine-d6 Hydrochloride (100μg/ml in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Tramadol-d6 Hydrochloride (1.0mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Trenbolone (1.0 mg/mL in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Trenbolone-d5 (1.0 mg/mL in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Tris(trideuteromethoxy)Mescaline-D9 Hydrochloride (0.1mg/1ml in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC Standards | Zolpidem (1.0 mg/mL in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC-Lipomed | N-Ethylpentylone.HCl, 1 mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 10/17/2025 |
| LGC-Lipomed | (-)-Delta-8-THC, 1mg/ml in Ethanol | Glass Ampule: 1 ml | 7/24/2025 |
| LGC-Lipomed | (-)-Delta-9-THC, 1mg/ml in Methanol | Ampule, Amber Glass: 1 mL | 11/21/2025 |
| LGC-Lipomed | (-)-trans-Delta-9-THC (Dronabinol), 1 mg/ml in Ethanol Prod No: LPM-THC-135-1LE | Glass Ampule: 1 ml | 7/23/2025 |
| LGC-Lipomed | (-)-trans-Delta-9-THC-D3 (Dronabinol), 0.1mg/ml in Ethanol | Glass Ampule: 1 ml | 8/5/2025 |
| LGC-Lipomed | (-)-trans-Delta-9-THC-D3 (Dronabinol), 1mg/ml in Ethanol | Glass Ampule: 1 ml | 8/5/2025 |
| LGC-Lipomed | (as free base) Prod No: LPM-PYR-1854-HC-0.1LM | Glass Ampule: 1 ml | 8/12/2025 |
| LGC-Lipomed | 0.1 mg/ml in Methanol Prod No: LPM-PHB-1720-FA-0.1LM | Glass Ampule: 1 ml | 8/12/2025 |
| LGC-Lipomed | 17Alpha-Methyltestosterone, 1mg/ml in Methanol | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | 1-Benzylpiperazine.2HCl, 1mg/ml in Acetonitrile/Water: 1/1 (as free base) | Glass Ampule: 1 ml | 10/13/2025 |
| ( printed page 13619) | | | |
| LGC-Lipomed | 25B-NB2OMe.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | 25C-NB2OMe.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | 25I-NB2OMe-D9.HCl, 0.1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | 25I-NB2OMe-D9.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | 2C-B.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | 2C-C.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | 2C-D.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | 2C-E.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | 2C-I.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | 2C-P.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | 2C-T-4.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | 2C-T-7.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | 3,4-Methylenedioxypyrovalerone.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | 3,4-Methylenedioxypyrovalerone-D8.HCl, 0.1 mg/ml in Methanol | Glass Ampule: 1 ml | 8/12/2025 |
| LGC-Lipomed | 3-Acetylmorphine.amidosulfonate, 1mg/ml in Acetonitrile/Water: 1/1 (as free base) | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | 3-Desmethylprodine.HCl (MPPP), 1mg/ml in Acetonitrile (as free base) | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | 3-Methylmethcathinone.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | 4-Ethylmethcathinone.HCl, 1mg/ml in Methanol (as free base) | Ampule, Amber Glass: 1 mL | 11/21/2025 |
| LGC-Lipomed | 4-Methylethcathinone.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | 4-Methylmethcathinone.HCl (Mephedrone), 1mg/ml in Methanol (as free base)
(Mephedrone), 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/5/2025 |
| LGC-Lipomed | 4-MethylmethcathinoneD3.HCl (Mephedrone), 0.1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | 4-MethylmethcathinoneD3.HCl (Mephedrone), 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/5/2025 |
| LGC-Lipomed | 5Alpha-Dihydrotestosterone, 1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | 5F-APINACA (5F-AKB-48), 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 9/18/2025 |
| LGC-Lipomed | 5F-APINACA (5F-AKB-48), 1mg/ml in Methanol | Glass Ampule: 1 ml | 9/18/2025 |
| LGC-Lipomed | 5F-PB-22, 0.1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | 5F-PB-22, 1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | 6-Acetylcodeine.HCl, 1mg/ml in Acetonitrile (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | 6-Acetylcodeine-D3.HCl, 1mg/ml in Acetonitrile (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | 6-Acetylmorphine.HCl.trihydrate, 1 mg/ml in Methanol (as free base) Prod No: LPM-M-43-HC-1LM | Glass Ampule: 1 ml | 7/23/2025 |
| LGC-Lipomed | 6-Acetylmorphine-D3.HCl.trihydrate, 0.1 mg/ml in Methanol (as free base) Prod No: LPM-M-44-HC-0.1LM | Glass Ampule: 1 ml | 8/12/2025 |
| LGC-Lipomed | 6-Acetylmorphine-D3.HCl.trihydrate, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 9/18/2025 |
| LGC-Lipomed | 6-Acetylmorphine-D6.HCl.trihydrate, 0.1 mg/ml in Methanol (as free base) Prod No: LPM-M-981-HC-0.1LM | Glass Ampule: 1 ml | 8/12/2025 |
| LGC-Lipomed | 6-Acetylmorphine-D6.HCl.trihydrate, 0.1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | 6-Acetylmorphine-D6.HCl.trihydrate, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | 6-Beta-Hydroxytestosterone, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | AB-CHMINACA, 0.1mg/ml in Acetonitrile | Ampule, Amber Glass: 1 mL | 11/21/2025 |
| LGC-Lipomed | AB-CHMINACA, 1mg/ml in Acetonitrile | Ampule, Amber Glass: 1 mL | 11/21/2025 |
| LGC-Lipomed | AB-FUBINACA, 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | AB-FUBINACA, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Acetylfentanyl-D5, 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | AH-7921.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | AKB-48 (APINACA), 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Allobarbital, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Alpha-PVP.HCl, 1mg/ml in Methanol | Glass ampule: 1 mL | 9/18/2025 |
| LGC-Lipomed | Alprazolam, 1mg/ml in Methanol | Glass Ampule: 1 ml | 9/18/2025 |
| LGC-Lipomed | Alprazolam-D5, 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Alprazolam-D5, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | AM-2201, 0.1mg/ml in Methanol | Ampule, Amber Glass: 1 mL | 11/21/2025 |
| LGC-Lipomed | AM-2201, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Amfepramone.HCl, 1mg/ml in Acetonitrile/Water: 1/1(as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Amobarbital sodium salt, 0.1mg/ml in Methanol (as free Acid) | Ampule, Amber Glass: 1 mL | 11/21/2025 |
| LGC-Lipomed | Androstenedione, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Anhydroecgonine methylester.HBr, 1mg/ml in Acetonitrile (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Anhydroecgonine methylester-D3.HBr, 0.1mg/ml in Acetonitrile (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Anhydroecgonine methylester-D3.HBr, 1mg/ml in Acetonitrile (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Anhydroecgonine.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Anhydroecgonine-D3.HCl, 0.1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Anhydroecgonine-D3.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Barbital, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Barbital-D5, 0.1mg/ml in Methanol 1 ml Ampule, Amber Glass | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Barbital-D5, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Benzoylecgonine, 1mg/ml in Methanol | Glass Ampule: 1 ml | 9/18/2025 |
| LGC-Lipomed | Benzoylecgonine-D3.tetrahydrate, 0.1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Benzoylecgonine-D3.tetrahydrate, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Benzoylecgonine-D8, 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Benzoylecgonine-D8, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Boldenone, 1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 8/5/2025 |
| ( printed page 13620) | | | |
| LGC-Lipomed | Bromazepam, 1mg/ml in Methanol | Glass Ampule: 1 ml | 9/18/2025 |
| LGC-Lipomed | Bromazepam-D4, 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Bromazepam-D4, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Bufotenine.oxalate.monohydrate, 1mg/ml in Methanol (as free base) | Ampule, Amber Glass: 1 mL | 11/21/2025 |
| LGC-Lipomed | Buphedrone.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Buprenorphine.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Buprenorphine-3-Beta-D-glucuronide, 0.1mg/ml in Methanol 0.1 mg/ml in 1 ml Methanol | Glass Ampule: 1 ml | 10/17/2025 |
| LGC-Lipomed | Buprenorphine-3-Beta-D-glucuronide, 1mg/ml in Acetonitrile/Water: 1/1 | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Buprenorphine-D4.HCl, 0.1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Buprenorphine-D4.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Butabarbital, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/5/2025 |
| LGC-Lipomed | Butalbital, 1 mg/ml in Methanol Prod No: LPM-BUT-871-FA-1LM | Glass Ampule: 1 ml | 7/23/2025 |
| LGC-Lipomed | Butalbital, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/5/2025 |
| LGC-Lipomed | Butalbital-D5, 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 9/18/2025 |
| LGC-Lipomed | Butylone.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Butylone-D3.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Cannabidiolic acid (CBDA), 1 mg/ml in Acetonitrile | Glass Ampule: 1 ml | 10/17/2025 |
| LGC-Lipomed | Carisoprodol, 1mg/ml in Methanol | Ampule, Amber Glass: 1 mL | 11/21/2025 |
| LGC-Lipomed | Carisoprodol-D7, 0.1mg/ml in Methanol | Glass ampule: 1 mL | 9/18/2025 |
| LGC-Lipomed | Carisoprodol-D7, 1mg/ml in Methanol | Glass ampule: 1 mL | 9/18/2025 |
| LGC-Lipomed | Chlordiazepoxide-D5, 0.1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Chlordiazepoxide-D5, 1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Chlorodehydromethyl-testosterone, 1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Clobazam, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/5/2025 |
| LGC-Lipomed | Clobazam, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Clonazepam-D4, 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Clonazepam-D4, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Clotiazepam, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Cocaethylene-D3, 0.1mg/ml in Acetonitrilee) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Cocaethylene-D3, 1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Cocaine-D3, 0.1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 8/5/2025 |
| LGC-Lipomed | Cocaine-D3, 1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Cocaine-D3.HCl, 0.1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Cocaine-D3.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Codeine.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 9/18/2025 |
| LGC-Lipomed | Codeine.monohydrate, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 9/18/2025 |
| LGC-Lipomed | Codeine-6-Beta-D-glucuronide.TFA, 1 mg/ml in Water (as free base) | Glass Ampule: 1 ml | 10/17/2025 |
| LGC-Lipomed | Codeine-6-Beta-D-glucuronide.TFA, 1mg/ml in Water (as free base) | Ampule, Amber Glass: 1 mL | 11/21/2025 |
| LGC-Lipomed | Codeine-6-Beta-D-glucuronide-D3.TFA, 0.1mg/ml in Acetonitrile/Water: 1/1 (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Codeine-6-Beta-D-glucuronide-D3.TFA, 1mg/ml in Acetonitrile/Water: 1/1 (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Codeine-D3.HCl.dihydrate, 0.1mg/ml in Ethanol (as free base) | Glass Ampule: 1 ml | 9/18/2025 |
| LGC-Lipomed | Codeine-D3.HCl.dihydrate, 1 mg/ml in Ethanol (as free base) Prod No: LPM-C-41-HC-1LE | Glass Ampule: 1 ml | 8/12/2025 |
| LGC-Lipomed | Codeine-D6, 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 8/5/2025 |
| LGC-Lipomed | Codeine-D6, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | d,l-11-Hydroxy-delta-9-THC, 1 mg/l in Methanol Prod No: LPM-THC-318-1LM | Glass Ampule: 1 ml | 7/23/2025 |
| LGC-Lipomed | d,l-2,4,5-TMA.HCl, 1mg/ml in Acetonitrile/Water: 1/1 (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | d,l-2,4,5-TMA.HCl, 1mg/ml in Acetonitrile/Water: 1/1 (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | d,l-2,5-DMA.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | d,l-3,4-DMA.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | d,l-Amphetamine.HCl, 1 mg/ml in Methanol (as free base) Prod No: LPM-AMP-95-HC-1LM | Glass Ampule: 1 ml | 7/23/2025 |
| LGC-Lipomed | d,l-Amphetamine.sulfate, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | d,l-Amphetamine-D11.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | d,l-Amphetamine-D5.HCl, 0.1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/5/2025 |
| LGC-Lipomed | d,l-Amphetamine-D5.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 9/18/2025 |
| LGC-Lipomed | d,l-Amphetamine-D6.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | d,l-BDB.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | d,l-Cathinone.HCl, 1mg/ml in Acetonitrile/Water: 1/1 (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | d,l-cis-3-Methylfentanyl.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | d,l-DOB.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | d,l-DOET.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | d,l-DOM.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | d,l-Fenproporex.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | d,l-MBDB.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | d,l-MBDB-D5.HCl, 0.1mg/ml in Methanol (as free base) | Glass ampoule: 1 mL | 12/10/2025 |
| LGC-Lipomed | d,l-MBDB-D5.HCl, 1mg/ml in Methanol (as free base) | Glass ampoule: 1 mL | 12/12/2025 |
| LGC-Lipomed | d,l-MDA.HCl, 1mg/ml in Methanol (as free base) Prod No: LPM-MDA-79-HC-1LM | Glass Ampule: 1 ml | 7/23/2025 |
| LGC-Lipomed | d,l-MDA-D5.HCl, 0.1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | d,l-MDA-D5.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | d,l-MDDMA.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | d,l-MDEA-D5.HCl, 0.1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | d,l-MDEA-D5.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | d,l-MDMA.HCl, 1 mg/ml in Methanol (as free base) Prod No: LPM-MDM-94-HC-1LM | Glass Ampule: 1 ml | 7/23/2025 |
| ( printed page 13621) | | | |
| LGC-Lipomed | d,l-MDMA-D3.HCl, 0.1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | d,l-MDMA-D3.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | d,l-MDMA-D5.HCl, 0.1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | d,l-MDMA-D5.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | d,l-Metamfepramone.HCl, 1mg/ml in Acetonitrile/Water: 1/1 (as free base) | Ampule, Amber Glass: 1 mL | 11/21/2025 |
| LGC-Lipomed | d,l-Methadone-D3.HCl, 0.1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | d,l-Methadone-D3.HCl, 1 mg/ml in Methanol (as free base) Prod No: LPM-MET-700-HC-1LM | Glass Ampule: 1 ml | 8/12/2025 |
| LGC-Lipomed | d,l-Methadone-D9.HCl, 0.1mg/ml in Methanol (as free base) | Ampule, Amber Glass: 1 mL | 11/21/2025 |
| LGC-Lipomed | d,l-Methadone-D9.HCl, 1 mg/ml in Methanol (as free base) Prod No: LPM-MET-1197-HC-1LM | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | d,l-Methamphetamine.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 9/18/2025 |
| LGC-Lipomed | d,l-Methamphetamine-D14.HCl, 0.1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | d,l-Methamphetamine-D14.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | d,l-Methamphetamine-D5.HCl, 0.1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | d,l-Methamphetamine-D5.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | d,l-Methcathinone.HCl, 1mg/ml in Acetonitrile (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | d,l-Methiopropamine.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | d,l-Methylphenidate.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 9/18/2025 |
| LGC-Lipomed | d,l-N,N- Dimethylamphetamine.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | d,l-N-Ethylamphetamine.HCl, 1 mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 10/17/2025 |
| LGC-Lipomed | d,l-PMA.HCl, 1mg/ml in Methanol (as free base) | Ampule, Amber Glass: 1 mL | 11/21/2025 |
| LGC-Lipomed | d,l-PMA-D3.HCl, 0.1 mg/ml in Methanol (as free base) Prod No: LPM-PMA-1941-HC-0.1LM | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | d,l-PMA-D3.HCl, 1 mg/ml in Methanol (as free base) Prod No: LPM-PMA-1941-HC-1LM | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | d,l-PMMA.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | d,l-Propoxyphene-D5.HCl, 0.1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/5/2025 |
| LGC-Lipomed | d,l-threo- Methylphenidate-D10.HCl, 0.1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | d,l-threo-Ethylphenidate.HCl,1mg/ml in Ethanol (as free base) | Glass ampoule: 1 mL | 12/12/2025 |
| LGC-Lipomed | d,l-trans-Tilidine.HCl.hemihydrate, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | d-Amphetamine.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | d-Amphetamine.sulfate, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | d-Cathine.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Delorazepam, 1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Desmethyldiazepam (Nordazepam), 1 mg/ml in Methanol Prod No: LPM-DIA-108-1LM | Glass Ampule: 1 ml | 7/23/2025 |
| LGC-Lipomed | Desmethyldiazepam-D5 (Nordazepam-D5), 0.1mg/ml in Methanol | Glass ampule: 1 mL | 9/25/2025 |
| LGC-Lipomed | Desmethyldiazepam-D5 (Nordazepam-D5), 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Desomorphine, 1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Diazepam, 1 mg/ml in Methanol Prod No: LPM-DIA-107-1LM | Glass Ampule: 1 ml | 7/23/2025 |
| LGC-Lipomed | Diazepam-D3, 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Diazepam-D3, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Diazepam-D5, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Dihydrocodeine.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Dihydrocodeine-D6.HCl, 0.1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Dihydrocodeine-D6.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Dihydromorphine-6-Beta-D-glucuronide, 1mg/ml in Acetonitrile/Water: 1/1
Acetonitrile/Water: 1/1 | Glass Ampule: 1 ml | 7/24/2025 |
| LGC-Lipomed | d-Methamphetamine.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | d-Propoxyphene.HCl, 1 mg/ml in Methanol (as free base) Prod No: LPM-PPO-697-HC-1LM | Glass Ampule: 1 ml | 7/23/2025 |
| LGC-Lipomed | Ecgonine methylester.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/5/2025 |
| LGC-Lipomed | Ecgonine methylester-D3.FB, 0.1mg/ml in Acetonitrile | Glass ampoule: 1 mL | 12/10/2025 |
| LGC-Lipomed | Ecgonine methylester-D3.FB,1mg/ml in Acetonitrile | Glass ampoule: 1 mL | 12/10/2025 |
| LGC-Lipomed | Ecgonine methylester-D3.HCl, 0.1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Ecgonine methylester-D3.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Ecgonine.HCl, 1 mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 10/17/2025 |
| LGC-Lipomed | Ecgonine-D3.HCl, 1mg/ml in Methanol (as free base) | Ampule, Amber Glass: 1 mL | 11/21/2025 |
| LGC-Lipomed | Estazolam, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Ethcathinone.HCl, 1mg/ml in Acetonitrile (as free base) | Ampule, Amber Glass: 1 mL | 11/21/2025 |
| LGC-Lipomed | Ethylmorphine.HCl.dihydrate, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Ethylone.HCl, 1mg/ml in Methanol (as free base) | Ampule, Amber Glass: 1 mL | 11/21/2025 |
| LGC-Lipomed | Fenethylline.HCl, 1mg/ml in Methanol (as free base) | Ampule, Amber Glass: 1 mL | 11/21/2025 |
| LGC-Lipomed | Fenethylline-D3.HCl, 0.1mg/ml in Methanol (as free base) | Ampule, Amber Glass: 1 mL | 11/21/2025 |
| LGC-Lipomed | Fenethylline-D3.HCl, 1mg/ml in Methanol (as free base) | Ampule, Amber Glass: 1 mL | 11/21/2025 |
| LGC-Lipomed | Fentanyl, 1mg/ml in Methanol Prod No: LPM-FEN-622-FB-1LM | Glass Ampule: 1 ml | 7/23/2025 |
| LGC-Lipomed | Fentanyl-D5, 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Flephedrone.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Flualprazolam, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Fludiazepam, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Flunitrazepam, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Flunitrazepam-D3, 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Flunitrazepam-D3, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Flunitrazepam-D7, 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Flunitrazepam-D7, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Fluoxymesterone, 1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 8/14/2025 |
| ( printed page 13622) | | | |
| LGC-Lipomed | Flurazepam, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | GHB.sodium salt, 1 mg/ml in Methanol Prod No: LPM-GHB-538-NA-1LM | Glass Ampule: 1 ml | 7/23/2025 |
| LGC-Lipomed | GHB-D6.sodium salt, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Heroin.HCl.monohydrate, 1mg/ml in Acetonitrile (as free base) | Glass Ampule: 1 ml | 7/24/2025 |
| LGC-Lipomed | Heroin-D3 (3,6-Diacetylmorphine-D3), 0.1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 9/18/2025 |
| LGC-Lipomed | Heroin-D3 (3,6-Diacetylmorphine-D3), 1mg/ml in Acetonitrile | Ampule, Amber Glass: 1 mL | 11/21/2025 |
| LGC-Lipomed | Heroin-D3.HCl.monohydrate, 0.1mg/ml in Acetonitrile (as free base) | Ampule, Amber Glass: 1 mL | 11/21/2025 |
| LGC-Lipomed | Heroin-D3.HCl.monohydrate, 1mg/ml in Acetonitrile (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Heroin-D9 (3,6-Diacetylmorphine-D9), 0.1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Heroin-D9 (3,6-Diacetylmorphine-D9), 1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Hexobarbital, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | HU-210, 0.1mg/ml in Methanol | Glass ampule: 1 mL | 12/16/2025 |
| LGC-Lipomed | HU-210, 1mg/ml in Methanol | Glass ampule: 1 mL | 12/16/2025 |
| LGC-Lipomed | Hydrocodone, 1mg/ml in Methanol Prod No: LPM-C-405-FB-1LM | Glass Ampule: 1 ml | 7/23/2025 |
| LGC-Lipomed | Hydrocodone-D3, 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Hydrocodone-D3, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Hydrocodone-D6, 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Hydrocodone-D6, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Hydromorphone, 1 mg/ml in Methanol Prod No: LPM-M-407-FB-1LM | Glass Ampule: 1 ml | 7/23/2025 |
| LGC-Lipomed | Hydromorphone-D3, 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 9/18/2025 |
| LGC-Lipomed | Hydromorphone-D3, 1mg/ml in Methanol | Glass Ampule: 1 ml | 9/18/2025 |
| LGC-Lipomed | JWH-018, 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | JWH-018, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | JWH-018-D11, 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | JWH-018-D11, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | JWH-019, 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 9/18/2025 |
| LGC-Lipomed | JWH-019, 1mg/ml in Methanol | Glass Ampule: 1 ml | 9/18/2025 |
| LGC-Lipomed | JWH-073, 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | JWH-073, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | JWH-081, 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | JWH-081, 1mg/ml in Methanol | Ampule, Amber Glass: 1 mL | 11/21/2025 |
| LGC-Lipomed | JWH-122, 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 9/18/2025 |
| LGC-Lipomed | JWH-122, 1mg/ml in Methanol | Glass Ampule: 1 ml | 9/18/2025 |
| LGC-Lipomed | JWH-200, 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 9/18/2025 |
| LGC-Lipomed | JWH-200, 1mg/ml in Methanol | Glass Ampule: 1 ml | 9/18/2025 |
| LGC-Lipomed | JWH-250, 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 8/5/2025 |
| LGC-Lipomed | JWH-250, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/5/2025 |
| LGC-Lipomed | Ketamine.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 9/18/2025 |
| LGC-Lipomed | l-Amphetamine.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 7/24/2025 |
| LGC-Lipomed | l-Methamphetamine.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Loprazolam, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Lorazepam, 1 mg/ml in Acetonitrile Prod No: LPM-LOR-142-1LA | Glass Ampule: 1 ml | 7/23/2025 |
| LGC-Lipomed | Lorazepam-D4, 0.1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Lorazepam-D4, 1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Lormetazepam, 1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 9/18/2025 |
| LGC-Lipomed | Lormetazepam-D3, 0.1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 9/18/2025 |
| LGC-Lipomed | Lormetazepam-D3, 1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | LPM-AMB-400-NA-1LM | Glass Ampule: 1 ml | 7/28/2025 |
| LGC-Lipomed | LPM-AMP-976-HC-0.1LM | Glass Ampule: 1 ml | 7/28/2025 |
| LGC-Lipomed | LPM-BUT-1637-FA-1LM | Glass Ampule: 1 ml | 7/28/2025 |
| LGC-Lipomed | LPM-CHL-147-FB-1LA | Glass Ampule: 1 ml | 7/28/2025 |
| LGC-Lipomed | LPM-CLO-105-1LM | Glass Ampule: 1 ml | 7/28/2025 |
| LGC-Lipomed | LPM-COC-156-FB-1LA | Glass Ampule: 1 ml | 7/28/2025 |
| LGC-Lipomed | LPM-COC-156-HC-1LM | Glass Ampule: 1 ml | 7/28/2025 |
| LGC-Lipomed | LPM-COC-207-FB-1LA | Glass Ampule: 1 ml | 7/28/2025 |
| LGC-Lipomed | LPM-DIA-826-0.1LM | Glass Ampule: 1 ml | 7/28/2025 |
| LGC-Lipomed | LPM-ETZ-1753-1LM | Glass Ampule: 1 ml | 7/28/2025 |
| LGC-Lipomed | LPM-FEN-622-FB-0.1LM | Glass Ampule: 1 ml | 7/28/2025 |
| LGC-Lipomed | LPM-M-29-FB-1LA | Glass Ampule: 1 ml | 7/28/2025 |
| LGC-Lipomed | LPM-MDE-191-HC-1LM | Glass Ampule: 1 ml | 7/28/2025 |
| LGC-Lipomed | LPM-MET-637-HC-1LM | Glass Ampule: 1 ml | 7/28/2025 |
| LGC-Lipomed | LPM-MPB-1541-1LM | Glass Ampule: 1 ml | 7/28/2025 |
| LGC-Lipomed | LPM-MPH-1675-HC-1LM | Glass Ampule: 1 ml | 7/28/2025 |
| LGC-Lipomed | LPM-OXA-860-0.1LA | Glass Ampule: 1 ml | 7/28/2025 |
| LGC-Lipomed | LPM-PCP-436-HC-1LM | Glass Ampule: 1 ml | 7/28/2025 |
| LGC-Lipomed | LPM-PPO-1360-HC-1LM | Glass Ampule: 1 ml | 7/28/2025 |
| LGC-Lipomed | LPM-PYR-1854-HC-1LM | Glass Ampule: 1 ml | 7/28/2025 |
| LGC-Lipomed | LPM-SCB-583-FA-1LM | Glass Ampule: 1 ml | 7/28/2025 |
| LGC-Lipomed | LPM-TEM-917-0.1LM | Glass Ampule: 1 ml | 7/28/2025 |
| LGC-Lipomed | LPM-TRI-124-FB-1LM | Glass Ampule: 1 ml | 7/28/2025 |
| LGC-Lipomed | LPM-ZOL-919-TA-1LM | Glass Ampule: 1 ml | 7/28/2025 |
| LGC-Lipomed | LSD-D3 (Lysergic acid diethylamide-D3), 0.1mg/ml in | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | LSD-D3 (Lysergic acid diethylamide-D3), 1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | MDMB-CHMICA, 1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Medazepam, 1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | Meperidine.HCl (Pethidine.HCl), 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | Meperidine-D4.HCl (Pethidine-D4.HCl), 0.1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | Meperidine-D4.HCl (Pethidine-D4.HCl), 1 mg/ml in Methanol (as free base) Prod No: LPM-MEP-1536-HC-1LM | Glass Ampule: 1 ml | 7/23/2025 |
| ( printed page 13623) | | | |
| LGC-Lipomed | Meprobamate, 1 mg/ml in Methanol Prod No: LPM-MPB-1142-1LM | Glass Ampule: 1 ml | 7/23/2025 |
| LGC-Lipomed | Meprobamate, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/5/2025 |
| LGC-Lipomed | Meprobamate-D7, 0.1 mg/ml in Methanol Prod No: LPM-MPB-1541-0.1LM | Glass Ampule: 1 ml | 8/12/2025 |
| LGC-Lipomed | Mescaline.HCl, 1mg/ml in Ethanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Metenolone enanthate, 1mg/ml in Isopropanol | Ampule, Amber Glass: 1 mL | 11/21/2025 |
| LGC-Lipomed | Methandienone, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Methaqualone, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/5/2025 |
| LGC-Lipomed | Methaqualone-D7, 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | Methaqualone-D7, 1mg/ml in Methanol | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | Methoxetamine.HCl, 1 mg/ml in Methanol (as free base) LPM-MXE-1527-HC-1LM | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Methylone.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | Methylone-D3.HCl, 0.1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | Methylone-D3.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | Midazolam, 1mg/ml in Methanol | Glass Ampule: 1 ml | 9/18/2025 |
| LGC-Lipomed | Midazolam-D4.maleate, 0.1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | Midazolam-D4.maleate, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | Morphine.monohydrate, 1mg/ml in Methanol (as free base) Prod No: LPM-M-35-FB-1LM | Glass Ampule: 1 ml | 7/23/2025 |
| LGC-Lipomed | Morphine.sulfate.pentahydrate, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 7/24/2025 |
| LGC-Lipomed | Morphine-3-Beta-D-glucuronide, 1mg/ml in Methanol/Water: 1/1 | Glass Ampule: 1 ml | 7/24/2025 |
| LGC-Lipomed | Morphine-3-Beta-D-glucuronide-D3, 0.1mg/ml in Methanol/Water: 1/1 | Glass Ampule: 1 ml | 9/18/2025 |
| LGC-Lipomed | Morphine-3-Beta-D-glucuronide-D3, 1mg/ml in Methanol/Water: 1/1 | Glass Ampule: 1 ml | 9/18/2025 |
| LGC-Lipomed | Morphine-6-Beta-D-glucuronide, 1mg/ml in Water | Glass Ampule: 1 ml | 7/24/2025 |
| LGC-Lipomed | Morphine-6-Beta-D-glucuronide-D3, 0.1mg/ml in Acetonitrile/Water: 1/1 | Glass Ampule: 1 ml | 9/18/2025 |
| LGC-Lipomed | Morphine-6-Beta-D-glucuronide-D3, 1mg/ml in Acetonitrile/Water: 1/1 | Glass Ampule: 1 ml | 9/18/2025 |
| LGC-Lipomed | Morphine-D3.monohydrate, 0.1 mg/ml in Methanol (as free base) Prod No: LPM-M-39-FB-1LM | Glass Ampule: 1 ml | 8/12/2025 |
| LGC-Lipomed | Morphine-D3.monohydrate, 0.1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 9/18/2025 |
| LGC-Lipomed | MPBP.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | N,N-Dimethyltryptamine, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Nalorphine.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Naloxone-3-Beta-D-glucuronide, 1mg/ml in Methanol/Water: 1/1 | Ampule, Amber Glass: 1 mL | 11/21/2025 |
| LGC-Lipomed | Nandrolone, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Naphyrone.HCl, 1mg/ml in Methanol (as free base) | Glass ampule: 1 mL | 9/25/2025 |
| LGC-Lipomed | N-Ethylpentylone.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 7/24/2025 |
| LGC-Lipomed | Nimetazepam, 1mg/ml in Methanol | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | Nitrazepam, 1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | Nitrazepam-D5, 0.1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | Nitrazepam-D5, 1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | Norbuprenorphine, 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 8/5/2025 |
| LGC-Lipomed | Norbuprenorphine, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Norbuprenorphine-D3, 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Norbuprenorphine-D3, 1 mg/ml in Methanol Prod No: LPM-BUP-1355-FB-1LM | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Norcocaine.HCl, 1mg/ml in Acetonitrile (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Norcodeine, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Norfentanyl.HCl, 0.1mg/ml in Methanol (as free base) | Ampule, Amber Glass: 1 mL | 11/21/2025 |
| LGC-Lipomed | Norfentanyl.HCl, 1mg/ml in Methanol (as free base) Prod No: LPM-FEN-632-HC-1LM | Glass Ampule: 1 ml | 7/23/2025 |
| LGC-Lipomed | Norfentanyl-D5.HCl, 0.1mg/ml in Methanol (as free base) | Ampule, Amber Glass: 1 mL | 11/21/2025 |
| LGC-Lipomed | Norfentanyl-D5.HCl, 1mg/ml in Methanol (as free base) | Ampule, Amber Glass: 1 mL | 11/21/2025 |
| LGC-Lipomed | Norhydrocodone.HCl, 1mg/ml in Acetonitrile/Water: 1/1(as free base) | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Norhydrocodone-D3.HCl, 0.1mg/ml in Methanol (as free base) | Ampule, Amber Glass: 1 mL | 11/21/2025 |
| LGC-Lipomed | Normeperidine.HCl, 1 mg/ml in Methanol (as free base) Prod No: LPM-MEP-1365-HC-1LM | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Normeperidine-D4.HCl, 0.1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Normeperidine-D4.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Normorphine.HCl.monohydrate, 1 mg/ml in Methanol (as free base) Prod No: LPM-M-34-HC-1LM | Glass Ampule: 1 ml | 8/12/2025 |
| LGC-Lipomed | Noroxycodone.HCl, 1 mg/ml in Methanol (as free base) Prod No: LPM-C-1598-HC-1LM | Glass Ampule: 1 ml | 7/23/2025 |
| LGC-Lipomed | Noroxymorphone.HCl, 1mg/ml in Methanol/Water: 1/1 (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Oxazepam, 1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 9/18/2025 |
| LGC-Lipomed | Oxazepam-D5, 1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | Oxycodone OCD3.HCl.monohydrate, 0.1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/5/2025 |
| LGC-Lipomed | Oxycodone.HCl.monohydrate, 1mg/ml in Methanol (as free base) Prod No: LPM-C-404-HC-1LM | Glass Ampule: 1 ml | 7/23/2025 |
| LGC-Lipomed | Oxycodone-D6.HCl.monohydrate, 0.1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Oxycodone-D6.HCl.monohydrate, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Oxycodone-OCD3.HCl.monohydrate, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Oxymetholone, 1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Oxymorphone, 1mg/ml in Methanol Prod No: LPM-M-406-FB-1LM | Glass Ampule: 1 ml | 7/23/2025 |
| LGC-Lipomed | Oxymorphone-D3, 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 8/5/2025 |
| LGC-Lipomed | Oxymorphone-D3, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | PB-22, 0.1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | PB-22, 1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 10/13/2025 |
| ( printed page 13624) | | | |
| LGC-Lipomed | PCP-D5.HCl (Phencyclidine-D5.HCl), 0.1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/5/2025 |
| LGC-Lipomed | PCP-D5.HCl (Phencyclidine-D5.HCl), 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/5/2025 |
| LGC-Lipomed | Pentedrone.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | Pentobarbital.sodium salt, 1mg/ml in Methanol (as free Acid) | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | Pentobarbital-D5, 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Pentobarbital-D5, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Pentylone.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | Pentylone-D3.HCl, 0.1mg/ml in Methanol (as free base) | Glass ampoule: 1 mL | 12/10/2025 |
| LGC-Lipomed | Pentylone-D3.HCl, 1mg/ml in Methanol (as free base) | Glass ampoule: 1 mL | 12/10/2025 |
| LGC-Lipomed | Phenmetrazine.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | Phenobarbital, 1 mg/ml in Methanol Prod No: LPM-PHB-376-FA-1LM | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Phenobarbital-D5 (side chain) | Glass Ampule: 1 ml | 8/12/2025 |
| LGC-Lipomed | Phenobarbital-D5 (side chain), 1 mg/ml in Methanol Prod No: LPM-PHB-1720-FA-1LM | Glass Ampule: 1 ml | 7/23/2025 |
| LGC-Lipomed | Phentermine.HCl, 1 mg/ml in Methanol (as free base) Prod No: LPM-PHE-844-HC-1LM | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Phentermine-D6.HCl, 0.1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | Phentermine-D6.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | Pholcodine.monohydrate, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Prazepam, 1mg/ml in Methanol | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | Prazepam-D5, 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | Prazepam-D5, 1mg/ml in Methanol | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | Pregabalin, 1mg/ml in Methanol | Ampule, Amber Glass: 1 mL | 11/21/2025 |
| LGC-Lipomed | Psilocin, 1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | Psilocybin, 1mg/ml in Acetonitrile/Water: 1/1 | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | Pyrovalerone.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | RCS-4, 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | RCS-4, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | S(-)-Cathinone.HCl, 1mg/ml in Acetonitrile/Water: 1/1 (as free base) | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Secobarbital, 1mg/ml in Methanol | Glass Ampule: 1 ml | 9/18/2025 |
| LGC-Lipomed | Secobarbital, 1mg/ml in Methanol | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | Secobarbital-D5, 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | Stanozolol, 1mg/ml in Acetonitrile | Ampule, Amber Glass: 1 mL | 11/21/2025 |
| LGC-Lipomed | Sufentanil-D5, 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | Tapentadol.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 9/18/2025 |
| LGC-Lipomed | Tapentadol-D3.HCl, 0.1 mg/ml in Methanol (as free base) Prod No: LPM-TAP-1809-HC-0.1LM | Glass Ampule: 1 ml | 8/12/2025 |
| LGC-Lipomed | Tapentadol-D3.HCl, 1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | Temazepam, 1 mg/ml in Methanol Prod No: LPM-TEM-123-1LM | Glass Ampule: 1 ml | 7/23/2025 |
| LGC-Lipomed | Temazepam-D5, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Testosterone, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Testosterone-D3, 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Testosterone-D3, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Tetrazepam, 1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | THCA-A, 1mg/ml in Isopropanol | Glass ampule: 1 mL | 9/25/2025 |
| LGC-Lipomed | Thebaine, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Thiopental, 1mg/ml in Methanol | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | Thiopental-D5, 1mg/ml in Methanol | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | Tramadol.HCl, 1mg/ml in Methanol (as free base) Prod No: LPM-TRA-779-HC-1LM | Glass Ampule: 1 ml | 7/23/2025 |
| LGC-Lipomed | Tramadol-O-CD3.HCl, 0.1mg/ml in Methanol (as free base) | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | trans-Cinnamoylcocaine, 1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Trenbolone acetate, 1 mg/ml in Isopropanol Prod No: LPM-TBL-1528-1LI | Glass Ampule: 1 ml | 8/12/2025 |
| LGC-Lipomed | Trenbolone acetate, 1mg/ml in Isopropanol | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Trenbolone, 1mg/ml in Acetonitrile | Ampule, Amber Glass: 1 mL | 11/21/2025 |
| LGC-Lipomed | Triazolam, 0.1mg/ml in Methanol | Ampule, Amber Glass: 1 mL | 11/21/2025 |
| LGC-Lipomed | U-47700, 1mg/ml in Methanol | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | UR-144, 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | UR-144, 1mg/ml in Methanol | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | XLR-11, 0.1mg/ml in Methanol | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | XLR-11, 1mg/ml in Methanol | Glass Ampule: 1 ml | 10/13/2025 |
| LGC-Lipomed | Zaleplon, 1mg/ml in Methanol | Ampule, Amber Glass: 1 mL | 11/21/2025 |
| LGC-Lipomed | Zolpidem-D6.tartrate, 0.1 mg/ml in Methanol (as free base) Prod No: LPM-ZOL-920-TA-0.1LM | Glass Ampule: 1 ml | 8/12/2025 |
| LGC-Lipomed | Zolpidem-D6.tartrate, 1mg/ml in Methanol (as free base) | Glass ampule: 1 mL | 9/25/2025 |
| LGC-Lipomed | Zopiclone, 1 mg/ml in Acetonitrile Prod No: LPM-ZOP-921-FB-1LA | Glass Ampule: 1 ml | 8/13/2025 |
| LGC-Lipomed | Zopiclone-D4, 0.1mg/ml in Acetonitrile | Ampule, Amber Glass: 1 mL | 11/21/2025 |
| LGC-Lipomed | Zopiclone-D4, 1mg/ml in Acetonitrile | Ampule, Amber Glass: 1 mL | 11/21/2025 |
| LGC-TRC | ADB-FUBINACA (1 mg/mL in Methanol) | Glass ampoule: 1 mL | 11/28/2025 |
| LGC-TRC | Androstanolone-d3 (1.0 mg/ml in Methanol) | Glass ampoule: 1 mL | 11/28/2025 |
| LGC-TRC | Calusterone (1.0mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 11/28/2025 |
| LGC-TRC | Clobazam-d5 (1 mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 11/28/2025 |
| LGC-TRC | L-threo-Methylphenidate Hydrochloride (1.0mg/ml in Methanol) | Glass ampoule: 1 mL | 11/28/2025 |
| LGC-TRC | MDMA Hydrochloride (1.0mg/ml in Methanol) | Glass ampoule: 1 mL | 11/28/2025 |
| LGC-TRC | MDMA-d3 Hydrochloride (1 mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 11/28/2025 |
| LGC-TRC | Nimetazepam-d3 (1.0 mg/ml in Methanol) | Glass ampoule: 1 mL | 11/28/2025 |
| LGC-TRC | rac Benzphetamine Hydrochloride (1.0mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 11/28/2025 |
| ( printed page 13625) | | | |
| LGC-TRC | Thiopental (1 mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 11/28/2025 |
| Lin-Zhi International | LZI Fentanyl Calibrator (Urine) Fentanyl, Cutoff Calibrator Ref# 0973 | Dropper Bottle: 5 mL | 6/2/2025 |
| Lin-Zhi International | LZI Fentanyl Calibrator (Urine) Fentanyl, Cutoff Calibrator Ref# 0983 | Dropper bottle: 5 mL | 7/3/2025 |
| Lin-Zhi International | LZI Fentanyl Calibrator (Urine) Fentanyl, High Calibrator Ref# 0985 | Dropper bottle: 5 mL | 7/3/2025 |
| Lin-Zhi International | LZI Fentanyl Calibrator (Urine) Fentanyl, Intermediate Calibrator Ref# 0984 | Dropper bottle: 5 mL | 7/3/2025 |
| Lin-Zhi International | LZI Fentanyl Calibrator/Control (Urine) Fentanyl, Low Calibrator/Level 1 Control Ref# 0982 | Dropper bottle: 5 mL | 7/3/2025 |
| Lin-Zhi International | LZI Fentanyl Control (Urine) Fentanyl, Level 1 Control Ref# 0977 | Dropper Bottle: 5 mL | 6/2/2025 |
| Lin-Zhi International | LZI Fentanyl Control (Urine) Fentanyl, Level 2 Control Ref# 0978 | Dropper Bottle: 5 mL | 6/2/2025 |
| Lin-Zhi International | LZI Fentanyl Control (Urine) Fentanyl, Level 2 Control Ref# 0988 | Dropper bottle: 5 mL | 7/3/2025 |
| Lin-Zhi International | LZI Fentanyl Level 1 Control, Ref# D26785 | Dropper bottle: 5 mL | 4/28/2025 |
| Lin-Zhi International | LZI Fentanyl Level 2 Control, Ref# D26786 | Dropper bottle: 5 mL | 4/28/2025 |
| Lin-Zhi International | LZI Fentanyl Qualitative Calibrator, Ref# D26784 | Dropper bottle: 5 mL | 4/28/2025 |
| Lipomed Inc | 1 mL Meprobamate-D7 solution (0.1 mg/mL methanol) | Amber ampule: 1 mL | 5/29/2025 |
| Lipomed Inc | Meprobamate D7 Solution Catalog number: MPB-1541-1LM | Glass ampule: 1 mL | 5/14/2025 |
| Lipomed Inc | Meprobamate solution Catalog number: MPB-1142-1LM | Glass ampule: 1 mL | 5/14/2025 |
| Lipomed Inc | Normorphine HCl hydrate, 1 mg/ml methanol Catalog number: M-34-HC-1LM | Glass ampule: 1 mL | 5/14/2025 |
| Microgenics Corporation | Cal MD 1 Alqt, Catalog number: 10009246 | Plastic tube: 1-50 mL | 6/23/2025 |
| Microgenics Corporation | Cal MD 1 Bulk, Catalog number: 1587 | Plastic tube: 1-50 mL | 6/23/2025 |
| Microgenics Corporation | Cal MD 2 Alqt, Catalog number: 10008921 | Plastic tube: 1-50 mL | 6/23/2025 |
| Microgenics Corporation | Cal MD 2 Bulk, Catalog number: 10008924 | Plastic tube: 1-50 mL | 6/23/2025 |
| Microgenics Corporation | Cal MD 3 Alqt, Catalog number: 10009247 | Plastic tube: 1-50 mL | 6/23/2025 |
| Microgenics Corporation | Cal MD 3 Bulk, Catalog number: 1593 | Plastic tube: 1-50 mL | 6/23/2025 |
| Microgenics Corporation | Cal MD 4 Alqt, Catalog number: 10008923 | Plastic tube: 1-50 mL | 6/23/2025 |
| Microgenics Corporation | Cal MD 4 Bulk, Catalog number: 10008925 | Plastic tube: 1-50 mL | 6/23/2025 |
| Microgenics Corporation | Cal MD Clinical C/O, Catalog number: 10000846 | Plastic tube: 1-50 mL | 6/23/2025 |
| Microgenics Corporation | Cal MD Low Alqt BCI, Catalog number: 10008920 | Plastic tube: 1-50 mL | 6/23/2025 |
| Microgenics Corporation | Ctrl MD Clinical High, Catalog number: 10009326 | Plastic tube: 1-50 mL | 6/23/2025 |
| Microgenics Corporation | Ctrl MD Clinical Low, Catalog number: 10009325 | Plastic tube: 1-50 mL | 6/23/2025 |
| Microgenics Corporation | Ctrl MD High | Plastic tube: 1-50 mL; Glass vial: 1-30 mL | 6/30/2025 |
| Microgenics Corporation | Ctrl MD Intermediate | Plastic tube: 1-50 mL; Glass vial: 1-30 mL | 6/30/2025 |
| Microgenics Corporation | Ctrl MD Primary Hi Alqt, Catalog number: 10007726 | Plastic tube: 1-50 mL | 6/23/2025 |
| Microgenics Corporation | Ctrl MD Primary Low Alqt, Catalog number: 10007725 | Plastic tube: 1-50 mL | 6/23/2025 |
| Microgenics Corporation | Ctrl MD Select High, Catalog number: 10009328 | Plastic tube: 1-50 mL | 6/23/2025 |
| Microgenics Corporation | Ctrl MD Select Low, Catalog number: 10009327 | Plastic tube: 1-50 mL | 6/23/2025 |
| Microgenics Corporation | Ctrl Tox L1 | Glass vial: 1-25 mL | 6/30/2025 |
| Microgenics Corporation | Ctrl Tox L1 | Plastic tube: 1-50 mL | 6/19/2025 |
| Microgenics Corporation | Ctrl Tox L2 | Glass vial: 1-25 mL | 6/30/2025 |
| Microgenics Corporation | Ctrl Tox L2 | Plastic tube: 1-50 mL | 6/19/2025 |
| Microgenics Corporation | Ctrl Tox L3 | Glass vial: 1-25 mL | 6/30/2025 |
| Microgenics Corporation | Ctrl Tox L3 | Plastic tube: 1-50 mL | 6/19/2025 |
| Microgenics Corporation | DAI PHENO ANTI REAGENT BULK | HDPE bottles: 30 mL, 125 mL, 500 mL, 1L, 4L | 12/23/2024 |
| Microgenics Corporation | MAS Liquimmune Control Sample Pack, Level 1, Catalog number: LG-S1 | Kit: 3 Glass vials, 5 ml each | 8/22/2025 |
| Microgenics Corporation | MAS Omni•IMMUNE Max, Level 1 | Kit: 12 bottles, 4 mL each | 6/6/2025 |
| Microgenics Corporation | MAS Omni•IMMUNE Max, Level 2 | Kit: 12 bottles, 4 mL each | 6/6/2025 |
| Microgenics Corporation | MAS Omni•IMMUNE Max, Level 3 | Kit: 12 bottles, 4 mL each | 6/6/2025 |
| Microgenics Corporation | MAS Omni•IMMUNE Max, Sample Pack | Kit: 4 bottles, 4 mL each | 6/6/2025 |
| Microgenics Corporation | MAS Omni•IMMUNE PRO Max, Level 1 | Kit: 12 bottles, 4 mL each | 6/6/2025 |
| Microgenics Corporation | MAS Omni•IMMUNE PRO Max, Level 2 | Kit: 12 bottles, 4 mL each | 6/6/2025 |
| Microgenics Corporation | MAS Omni•IMMUNE PRO Max, Level 3 | Kit: 12 bottles, 4 mL each | 6/6/2025 |
| Microgenics Corporation | MAS Omni•IMMUNE PRO Max, Sample Pack | Kit: 4 bottles, 4 mL each | 6/6/2025 |
| Microgenics Corporation | SEK TDM Multi Calibrator Level B | 200 plastic bottles: 2 mL each | 12/23/2024 |
| Microgenics Corporation | SEK TDM Multi Calibrator Level C | 200 plastic bottles: 2 mL each | 12/23/2024 |
| Microgenics Corporation | SEK TDM Multi Calibrator Level D | 200 plastic bottles: 2 mL each | 12/23/2024 |
| Microgenics Corporation | SEK TDM Multi Calibrator Level E | 200 plastic bottles: 2 mL each | 12/23/2024 |
| Microgenics Corporation | SEK TDM Multi Calibrator Level F | 200 plastic bottles: 2 mL each | 12/23/2024 |
| Microgenics Corporation | UDAT Negative DDE | Glass vial: 1- 25 mL | 6/30/2025 |
| Microgenics Corporation | UDAT Negative DDE | Plastic tube: 1-50 mL | 6/19/2025 |
| Microgenics Corporation | UDAT Positive DDE | Glass vial: 1-25 mL | 6/30/2025 |
| Microgenics Corporation | UDAT Positive DDE | Plastic tube: 1-50 mL | 6/19/2025 |
| ( printed page 13626) | | | |
| National Laboratory Certification Program | 000748B, 022146B, 039665B, 065879B, 086495B, 167962B, 189994B, 204201B, 223508B, 326257B, 342610B, 362297B, 388879B, 416496B, 416692B, 433882B, 466557B, 473169B, 534816B, 540208B, 555457B, 560491B, 616284B, 629937B, 674164B, 791989B, 808165B, 822964B, 834011B, 868533B, 886220B, 895562B, 926768B, 940578B, 970440B, 143285B, 162515B, 199760B, 204187B, 317225B, 333143B, 341489B, 348010B, 355663B, 359531B, 367395B, 368690B, 389063B, 469290B, 475478B, 483045B, 496985B, 555622B, 570900B, 576653B, 585957B, 635733B, 639231B, 645544B, 679396B, 784787B, 793643B, 795124B, 806798B, 821428B, 857851B, 861892B, 916526B, 947534B, 989267B, 002986A, 287179A, 718678A, 818336A, 821154A, 893391A, 155057A, 554790A, 812009A, 889510A, 901346A, 938103A, 223328A, 485515A, 616924A, 617472A, 684380A, 898752A, 119337A, 276608A, 428933A, 649901A, 687449A, 728699A, 158060A, 358773A, 389046A, 470393A, 725377A, 921670A, 034905A, 050591A, 311762A, 435964A, 529986A, 716317A, 083960A, 103808A, 319701A, 504864A, 676139A, 778658A, 182558A, 410923A, 505805A, 564854A, 705577A, 766064A, 066780A, 388503A, 419282A, 703514A, 715394A, 773768A, 178093A, 192604A, 253434A, 263834A, 498855A, 936813A, 116696A, 255651A, 436569A, 848494A, 913694A, 976504A, 132812A, 259358A, 331715A, 453220A, 608037A, 642807A | HDPE Bottle: 35 mL | 8/13/2025 |
| National Laboratory Certification Program | 001249A, 027835A, 030319A, 031215A, 032972A, 045028A, 098349A, 143639A, 146293A, 151718A, 177210A, 211849A, 325597A, 326616A, 329074A, 369009A, 372913A, 386101A, 398816A, 402142A, 416660A, 472099A, 534581A, 576116A, 582362A, 618644A, 642058A, 764131A, 779639A, 789678A, 818507A, 846054A, 925961A, 955839A, 979057A, 002251A, 039767A, 044459A, 052855A, 131153A, 156921A, 189463A, 203800A, 229130A, 253334A, 355362A, 420342A, 440872A, 456611A, 461745A, 464814A, 465233A, 534153A, 534910A, 573090A, 574096A, 577592A, 580395A, 597215A, 620924A, 649927A, 667199A, 708662A, 735570A, 756401A, 781307A, 801348A, 863846A, 920213A, 943102A, 001338B, 027173B, 038705B, 078823B, 128894B, 131909B, 133259B, 145077B, 184325B, 188338B, 188939B, 209909B, 220208B, 224290B, 250754B, 293530B, 313052B, 323873B, 345844B, 346977B, 393206B, 408125B, 456318B, 457915B, 517816B, 568254B, 652003B, 781424B, 785507B, 893164B, 902439B, 908808B, 928191B, 970747B, 971845B, 000402B, 065269B, 073822B, 086729B, 088945B, 123047B, 152713B, 205449B, 232160B, 244650B, 278832B, 283716B, 295306B, 316453B, 341430B, 359561B, 415500B, 416036B, 432847B, 450059B, 457865B, 501988B, 549920B, 571836B, 595222B, 695275B, 709375B, 728251B, 734350B, 825509B, 845492B, 904645B, 914629B, 952576B, 981354B | HDPE Bottle: 35 mL | 8/13/2025 |
| National Laboratory Certification Program | 001420A, 002034A, 019847A, 046825A, 069432A, 106863A, 125298A, 130785A, 136251A, 142281A, 180198A, 241204A, 245078A, 252189A, 290580A, 329619A, 460489A, 472943A, 568919A, 582322A, 602719A, 606887A, 612695A, 615020A, 748717A, 830622A, 868748A, 887418A, 890295A, 897270A, 906694A, 925366A, 927921A, 967187A, 973838A, 004309A, 018662A, 056361A, 064122A, 163113A, 184110A, 228242A, 251018A, 261736A, 266037A, 279535A, 285644A, 306779A, 405300A, 436595A, 441065A, 496071A, 514158A, 555780A, 608102A, 635375A, 640429A, 657676A, 664073A, 672216A, 734185A, 749633A, 762926A, 767367A, 777431A, 809235A, 840766A, 926298A, 930286A, 956217A, 051635B, 125479B, 160680B, 210036B, 343967B, 359786B, 374204B, 416172B, 442106B, 443824B, 465401B, 473703B, 486996B, 489927B, 491951B, 520594B, 521686B, 540833B, 570333B, 589101B, 597293B, 667722B, 682374B, 692786B, 696196B, 745637B, 755762B, 786770B, 788285B, 794426B, 817555B, 819424B, 846959B, 979232B, 983529B, 010697B, 022117B, 082532B, 116752B, 158992B, 161172B, 177228B, 187457B, 210895B, 241426B, 256719B, 293088B, 343019B, 352986B, 373968B, 390864B, 439681B, 487844B, 517399B, 535038B, 548558B, 582459B, 603382B, 625105B, 677343B, 678234B, 681129B, 692457B, 743355B, 791000B, 861649B, 874492B, 966433B, 992475B, 997312B, 008337B, 044150B, 060118B, 073115B, 075429B, 110423B, 114425B, 119517B, 161266B, 194448B, 235805B, 248623B, 322304B, 386196B, 416931B, 432080B, 483918B, 499219B, 511508B, 512779B, 554565B, 580862B, 701044B, 709526B, 711598B, 763660B, 791308B, 800481B, 847740B, 880122B, 927402B, 942059B, 962277B, 983453B, 985611B | HDPE Bottle: 35 mL | 8/13/2025 |
| ( printed page 13627) | | | |
| National Laboratory Certification Program | 002607A, 005871A, 010267A, 037302A, 058133A, 167539A, 189120A, 198843A, 223547A, 265371A, 273521A, 312350A, 327096A, 345891A, 374572A, 408365A, 426333A, 430747A, 469762A, 541760A, 554350A, 556696A, 603613A, 710392A, 722293A, 758509A, 774160A, 789493A, 800127A, 800441A, 823141A, 868424A, 918975A, 932300A, 973219A, 005559A, 007056A, 060318A, 060822A, 066476A, 079813A, 102425A, 138323A, 145694A, 155454A, 189509A, 229111A, 232779A, 234600A, 304060A, 313103A, 315525A, 351952A, 355146A, 404250A, 406026A, 414442A, 452039A, 498752A, 536594A, 575118A, 580487A, 630920A, 642398A, 690233A, 716200A, 718990A, 830323A, 945302A, 999450A, 000076A, 002689A, 005336A, 049234A, 100803A, 114535A, 181701A, 228001A, 277225A, 278597A, 331643A, 342928A, 389298A, 429917A, 448030A, 491206A, 493791A, 510688A, 569993A, 570360A, 598460A, 600802A, 617482A, 636600A, 640755A, 657521A, 758933A, 823905A, 827065A, 862716A, 875677A, 932736A, 935933A, 976355A, 980632A, 031614A, 051459A, 055192A, 084650A, 120685A, 126722A, 138628A, 143247A, 167291A, 190985A, 278909A, 280854A, 308432A, 341946A, 388325A, 418652A, 436648A, 512595A, 562843A, 586726A, 613405A, 618722A, 654243A, 682929A, 712771A, 718431A, 725334A, 730258A, 748493A, 815920A, 830568A, 868491A, 900074A, 941441A, 959650A, 005666A, 037111A, 071132A, 076812A, 090023A, 092892A, 108325A, 140630A, 179204A, 194898A, 225953A, 235684A, 247574A, 294602A, 306264A, 353302A, 383694A, 389117A, 420372A, 423310A, 429254A, 516093A, 529371A, 569817A, 635297A, 684382A, 724258A, 788430A, 815134A, 831540A, 851045A, 858003A, 873167A, 876730A, 931413A | HDPE Bottle: 35 mL | 8/13/2025 |
| National Laboratory Certification Program | 003002B, 087649B, 088122B, 097213B, 101887B, 109259B, 180114B, 190602B, 203206B, 204793B, 237410B, 318221B, 358227B, 405127B, 429066B, 464574B, 516853B, 546815B, 595562B, 656679B, 660742B, 662693B, 725552B, 728964B, 744130B, 754517B, 779145B, 808978B, 854621B, 902372B, 928325B, 930057B, 963813B, 993756B, 999305B, 004978B, 038576B, 080314B, 128319B, 129675B, 130198B, 194423B, 219321B, 228240B, 251034B, 286189B, 353998B, 358075B, 367302B, 401038B, 423451B, 457306B, 457699B, 492914B, 543194B, 552087B, 584476B, 587475B, 590681B, 606849B, 644627B, 682369B, 741650B, 758544B, 796495B, 853450B, 898211B, 908182B, 943177B, 999833B, 035550B, 065643B, 147223B, 173202B, 198348B, 257417B, 260894B, 264336B, 273063B, 276178B, 341742B, 345229B, 392939B, 413817B, 425234B, 495163B, 498877B, 527143B, 570511B, 587850B, 605697B, 639581B, 672832B, 717588B, 761034B, 769013B, 785604B, 823221B, 850953B, 885621B, 886279B, 934228B, 958843B, 985085B, 988885B, 016331B, 063957B, 067948B, 088210B, 123687B, 126521B, 167760B, 191425B, 211323B, 226171B, 244664B, 254307B, 279094B, 279789B, 367446B, 369857B, 407954B, 439938B, 540642B, 550860B, 614669B, 674756B, 698083B, 714070B, 721652B, 749981B, 756040B, 782629B, 904051B, 904647B, 932582B, 936878B, 955214B, 974981B, 996596B, 078164B, 094520B, 103792B, 134474B, 152792B, 190116B, 217101B, 257863B, 270842B, 377549B, 408019B, 411878B, 442008B, 460982B, 527654B, 546971B, 601759B, 624614B, 644555B, 655484B, 720991B, 725388B, 742949B, 779193B, 848155B, 854070B, 868649B, 871225B, 881299B, 903977B, 907302B, 924305B, 934078B, 942833B, 967867B | HDPE Bottle: 35 mL | 8/13/2025 |
| ( printed page 13628) | | | |
| National Laboratory Certification Program | 006206A, 031006A, 032097A, 081261A, 084246A, 140135A, 210233A, 234088A, 240026A, 301517A, 307141A, 310037A, 345358A, 358639A, 370474A, 423752A, 471400A, 475502A, 512584A, 521655A, 526587A, 529780A, 572607A, 579690A, 587653A, 615917A, 654272A, 664802A, 696688A, 698228A, 729181A, 768474A, 798477A, 977241A, 981697A, 118988A, 142257A, 179713A, 179964A, 232600A, 286621A, 292618A, 293948A, 327668A, 345555A, 362272A, 365354A, 414624A, 428820A, 464467A, 515361A, 533550A, 634816A, 726842A, 752145A, 762614A, 775255A, 791702A, 817154A, 841712A, 846310A, 860581A, 866703A, 945560A, 950221A, 955729A, 964544A, 977024A, 982060A, 997896A, 020549A, 055873A, 091931A, 103313A, 109157A, 117989A, 123784A, 151693A, 164409A, 175764A, 277493A, 331825A, 346940A, 394608A, 399740A, 418376A, 499323A, 502924A, 508723A, 520961A, 523571A, 531629A, 552589A, 565640A, 623633A, 638624A, 662092A, 706843A, 730464A, 785155A, 819776A, 879645A, 921267A, 949214A, 996663A, 046762A, 100034A, 102666A, 103232A, 108718A, 138437A, 142638A, 148308A, 195427A, 225875A, 259980A, 280661A, 325899A, 333984A, 351003A, 367786A, 371858A, 388872A, 393645A, 398129A, 400359A, 448092A, 479095A, 570180A, 604666A, 607799A, 631374A, 634388A, 641041A, 659497A, 700446A, 748618A, 891470A, 901244A, 942711A | HDPE Bottle: 35 mL | 8/13/2025 |
| National Laboratory Certification Program | 010070B, 093360B, 099288B, 110882B, 156851B, 239750B, 257778B, 282207B, 288939B, 381045B, 383077B, 398549B, 413633B, 423826B, 479238B, 491081B, 516708B, 531816B, 566564B, 571215B, 576086B, 593527B, 615405B, 740193B, 743791B, 790154B, 802453B, 802705B, 838230B, 858148B, 877893B, 879636B, 900072B, 965444B, 993246B, 026024B, 026847B, 051721B, 063912B, 065871B, 118019B, 136680B, 140934B, 381235B, 389733B, 392446B, 427161B, 456104B, 516761B, 538741B, 548287B, 564163B, 569026B, 574913B, 586831B, 588082B, 626152B, 649482B, 651441B, 659617B, 662769B, 754785B, 777415B, 786123B, 855707B, 936715B, 946177B, 948013B, 963933B, 991376B, 021010A, 030707A, 239326A, 244246A, 337865A, 371198A, 372440A, 381287A, 393670A, 423618A, 436998A, 458904A, 468431A, 492785A, 496858A, 508735A, 515657A, 519381A, 527674A, 563720A, 596068A, 598978A, 670656A, 816957A, 829284A, 834707A, 868325A, 892665A, 917114A, 944490A, 963773A, 972897A, 982749A, 986672A, 989941A, 008075A, 017852A, 025625A, 085275A, 097999A, 102622A, 104451A, 187797A, 235223A, 237010A, 293294A, 293303A, 336061A, 346745A, 409856A, 412993A, 444251A, 454347A, 522107A, 546801A, 570924A, 584379A, 651757A, 704466A, 721935A, 722529A, 728478A, 805525A, 861781A, 909262A, 915497A, 940293A, 940584A, 963339A, 977072A, 001424A, 018549A, 032135A, 054089A, 100890A, 139000A, 154712A, 184394A, 201783A, 223037A, 227969A, 274516A, 289891A, 314567A, 325731A, 345973A, 384796A, 484282A, 539167A, 540312A, 574694A, 621396A, 645207A, 673320A, 675481A, 698635A, 700449A, 729705A, 831751A, 845276A, 931693A, 939711A, 958958A, 975696A, 998134A | HDPE Bottle: 35 mL | 8/13/2025 |
| ( printed page 13629) | | | |
| National Laboratory Certification Program | 014064A, 070455A, 072822A, 077919A, 096657A, 124962A, 259574A, 263776A, 357440A, 365600A, 378595A, 383326A, 405193A, 416442A, 437908A, 444539A, 464994A, 485246A, 494040A, 498674A, 647026A, 736635A, 736929A, 748417A, 755567A, 787193A, 792836A, 802250A, 852899A, 900360A, 902762A, 908964A, 947949A, 974384A, 983525A, 007292A, 009786A, 011918A, 016120A, 038168A, 067225A, 079531A, 081369A, 131969A, 161948A, 182862A, 192080A, 345914A, 357516A, 389524A, 447653A, 451580A, 481153A, 513678A, 544125A, 555636A, 582823A, 596073A, 626277A, 631392A, 718321A, 747102A, 752666A, 764944A, 765184A, 804514A, 806677A, 864601A, 925690A, 927292A, 025155A, 033235A, 049549A, 054034A, 055333A, 106472A, 118226A, 152283A, 234007A, 248041A, 280254A, 305280A, 314206A, 341828A, 348639A, 349011A, 389756A, 389759A, 396694A, 427443A, 487691A, 528175A, 546748A, 547344A, 633832A, 659937A, 694277A, 700514A, 741955A, 805262A, 853449A, 948027A, 953244A, 956598A, 962943A, 025920A, 027135A, 114480A, 115476A, 122523A, 183635A, 194041A, 204620A, 279945A, 281934A, 433932A, 433954A, 474972A, 480948A, 511809A, 526120A, 528097A, 590448A, 593901A, 615205A, 656931A, 706059A, 725830A, 750699A, 772302A, 783058A, 812667A, 828439A, 831789A, 848828A, 875358A, 885148A, 903531A, 907849A, 934986A, 051972A, 084295A, 092982A, 127246A, 144873A, 153363A, 179738A, 245433A, 267209A, 267239A, 268384A, 283952A, 302893A, 341922A, 366295A, 380954A, 431768A, 449924A, 472740A, 496108A, 520809A, 563533A, 610186A, 662154A, 666750A, 743040A, 743538A, 771036A, 831271A, 833772A, 845911A, 851457A, 875709A, 889988A, 905770A | HDPE Bottle: 35 mL | 8/13/2025 |
| National Laboratory Certification Program | 015148B, 056350B, 068497B, 068841B, 085299B, 088113B, 148813B, 216318B, 258353B, 278737B, 290602B, 342174B, 349555B, 363816B, 378841B, 383732B, 403899B, 425825B, 428748B, 435254B, 490430B, 511164B, 539146B, 592447B, 639188B, 775875B, 794570B, 814647B, 835479B, 852161B, 856746B, 922414B, 942915B, 980973B, 995461B, 005970B, 007113B, 020039B, 041744B, 052781B, 095638B, 103092B, 108093B, 116611B, 137712B, 205143B, 212652B, 313350B, 313731B, 352196B, 372176B, 380826B, 480873B, 549776B, 574513B, 587920B, 601385B, 626117B, 634280B, 694610B, 697129B, 704426B, 749265B, 816141B, 864803B, 884678B, 919924B, 931313B, 952073B, 985493B, 002168B, 091094B, 123006B, 136411B, 138459B, 148032B, 209330B, 253424B, 260107B, 282451B, 290338B, 346617B, 382639B, 445840B, 454896B, 489818B, 523851B, 543156B, 547523B, 562232B, 583813B, 594916B, 623448B, 640119B, 684220B, 684485B, 718954B, 742612B, 808392B, 834188B, 920223B, 934971B, 966650B, 974890B, 999564B, 016991B, 084133B, 107773B, 132664B, 140291B, 154688B, 179523B, 184408B, 184929B, 214543B, 230517B, 246989B, 309057B, 328136B, 356755B, 371493B, 373624B, 380166B, 471772B, 541159B, 570310B, 592389B, 612733B, 636707B, 663165B, 668464B, 674714B, 684429B, 752346B, 756252B, 778652B, 813551B, 822312B, 833656B, 903755B, 068902B, 129408B, 148954B, 158395B, 161710B, 175855B, 185324B, 231810B, 234867B, 265506B, 329791B, 368936B, 379924B, 396559B, 417733B, 478661B, 487350B, 488452B, 516316B, 544066B, 582266B, 611803B, 673201B, 681808B, 697475B, 735696B, 773267B, 802300B, 838980B, 858879B, 887888B, 888149B, 890755B, 909314B, 986916B | HDPE Bottle: 35 mL | 8/13/2025 |
| ( printed page 13630) | | | |
| National Laboratory Certification Program | 017433B, 017794B, 084500B, 101389B, 106040B, 141643B, 158480B, 164272B, 177758B, 253127B, 273524B, 301629B, 319519B, 368693B, 405795B, 456287B, 484201B, 535222B, 574190B, 577129B, 588516B, 599060B, 626474B, 643825B, 733276B, 751873B, 815188B, 818970B, 820321B, 837004B, 865225B, 929563B, 932571B, 957085B, 988665B, 008300B, 020955B, 048067B, 048586B, 122737B, 162828B, 166724B, 173251B, 183621B, 194965B, 273974B, 354675B, 355375B, 407080B, 414483B, 462906B, 473949B, 474305B, 597795B, 598394B, 617129B, 651745B, 718596B, 751654B, 754559B, 775606B, 851317B, 864538B, 912644B, 918278B, 935659B, 937963B, 959217B, 969407B, 987184B, 013040A, 042753A, 090506A, 103995A, 116292A, 152529A, 180585A, 202706A, 279567A, 336881A, 404722A, 404794A, 432772A, 446473A, 463980A, 503028A, 522915A, 556437A, 596439A, 599504A, 650995A, 652080A, 660807A, 668824A, 678286A, 696520A, 713748A, 765514A, 778427A, 821933A, 868611A, 871672A, 871840A, 890969A, 957414A, 032127A, 038866A, 057538A, 114154A, 156524A, 166013A, 169311A, 184029A, 206832A, 261215A, 271448A, 345295A, 350467A, 353002A, 364606A, 377739A, 390882A, 414211A, 427846A, 488084A, 554944A, 586620A, 644720A, 654539A, 720771A, 745258A, 788267A, 805560A, 821531A, 823897A, 840565A, 851174A, 879955A, 966286A, 985558A | HDPE Bottle: 35 mL | 8/13/2025 |
| National Laboratory Certification Program | 020384A, 022514A, 073773A, 077307A, 101061A, 112787A, 113934A, 221524A, 222169A, 344282A, 345454A, 382658A, 399299A, 409663A, 422937A, 443649A, 450388A, 453675A, 472094A, 481939A, 488379A, 510953A, 559989A, 601421A, 639428A, 688400A, 780138A, 820038A, 822796A, 843747A, 852287A, 907466A, 914112A, 936481A, 996819A, 021015A, 106941A, 153757A, 170127A, 219620A, 243009A, 245620A, 262466A, 267026A, 273002A, 284518A, 293098A, 304173A, 357980A, 362650A, 368667A, 372428A, 373763A, 465213A, 632670A, 637010A, 654256A, 667111A, 676396A, 685528A, 715997A, 729778A, 738401A, 746709A, 820035A, 824394A, 862464A, 899745A, 976984A, 990488A, 000698B, 005823B, 008668B, 009201B, 014868B, 035268B, 040795B, 093659B, 110364B, 235929B, 250025B, 284776B, 289781B, 334117B, 360362B, 365813B, 406620B, 416031B, 429433B, 436806B, 478435B, 532508B, 536440B, 660586B, 660715B, 666837B, 708785B, 726285B, 744732B, 774145B, 774646B, 814238B, 829662B, 889478B, 966310B, 123477B, 139407B, 153268B, 214442B, 235636B, 248028B, 320549B, 382536B, 418025B, 479495B, 517581B, 529280B, 580007B, 593081B, 620945B, 633779B, 637763B, 647421B, 647863B, 653460B, 702767B, 704973B, 751674B, 752439B, 755787B, 763707B, 803866B, 838175B, 847350B, 871386B, 879837B, 894329B, 904256B, 950064B, 963760B | HDPE Bottle: 35 mL | 8/13/2025 |
| National Laboratory Certification Program | 037106B, 064669B, 121593B, 175568B, 184654B, 190581B, 220221B, 234541B, 243913B, 251933B, 312685B, 451855B, 469650B, 482602B, 562752B, 633520B, 637702B, 656601B, 669256B, 703740B, 705237B, 724503B, 754388B, 759014B, 763713B, 828140B, 832428B, 852540B, 853172B, 878380B, 888424B, 889409B, 891234B, 920600B, 929262B, 006435B, 022475B, 057975B, 069059B, 071614B, 094628B, 109877B, 141409B, 203883B, 254945B, 281629B, 308778B, 341348B, 351807B, 356969B, 388686B, 436827B, 457296B, 465716B, 476139B, 495813B, 535278B, 593565B, 606005B, 609170B, 616608B, 625412B, 664929B, 698418B, 751564B, 786646B, 861767B, 901399B, 990896B, 992257B, 067740B, 078286B, 088864B, 096404B, 099168B, 118997B, 171831B, 177252B, 200941B, 208656B, 221471B, 225547B, 282454B, 300382B, 356362B, 444961B, 458435B, 492844B, 521133B, 577803B, 616481B, 637395B, 648786B, 655158B, 659453B, 666321B, 676368B, 739389B, 747694B, 763463B, 820524B, 855516B, 890690B, 896779B, 993870B, 003330B, 008663B, 008973B, 053985B, 066982B, 083150B, 113023B, 145688B, 167253B, 176429B, 221441B, 263850B, 296679B, 372537B, 377640B, 428944B, 454311B, 470693B, 495033B, 516375B, 533182B, 538284B, 593454B, 622069B, 625845B, 705271B, 731910B, 760440B, 762685B, 805687B, 867966B, 895987B, 909977B, 967691B, 984212B | HDPE Bottle: 35 mL | 8/13/2025 |
| ( printed page 13631) | | | |
| National Laboratory Certification Program | 040826A, 052946A, 054338A, 101202A, 145345A, 151289A, 168310A, 204415A, 230085A, 270947A, 283433A, 414966A, 426423A, 436865A, 449014A, 449143A, 449215A, 451210A, 483623A, 562787A, 592758A, 597446A, 599811A, 661841A, 694951A, 701824A, 711740A, 728471A, 774161A, 788362A, 810255A, 866775A, 869369A, 871219A, 977467A, 028735A, 035118A, 075272A, 076547A, 089441A, 089633A, 096802A, 172073A, 259781A, 270806A, 321625A, 325690A, 350232A, 411793A, 450765A, 486819A, 563260A, 579818A, 591467A, 607282A, 624678A, 652701A, 699573A, 711491A, 715428A, 729140A, 771556A, 799742A, 838530A, 844041A, 855547A, 868513A, 882175A, 963272A, 65733A, 083318B, 097153B, 112864B, 120304B, 154929B, 184979B, 235136B, 260884B, 269738B, 270105B, 292616B, 363773B, 395431B, 404299B, 515262B, 552528B, 553217B, 604151B, 609472B, 696552B, 731845B, 741227B, 747141B, 760020B, 763677B, 785318B, 814115B, 819068B, 843696B, 847131B, 852064B, 905874B, 926529B, 936154B, 946776B, 003840B, 054021B, 057907B, 158728B, 201571B, 253068B, 259551B, 389566B, 523985B, 541941B, 542929B, 551906B, 562803B, 571097B, 571967B, 588134B, 608694B, 625732B, 656666B, 716335B, 745469B, 752927B, 764848B, 810619B, 859259B, 891730B, 943186B, 943972B, 946645B, 950528B, 952199B, 966997B, 970967B, 994669B, 998558B, 004421B, 021501B, 029943B, 031233B, 047450B, 075949B, 076140B, 115350B, 124299B, 133903B, 170676B, 174509B, 210376B, 298568B, 320140B, 350155B, 350399B, 364976B, 380599B, 391717B, 475430B, 514141B, 565435B, 565633B, 569655B, 639511B, 732980B, 762516B, 839143B, 852208B, 861253B, 877995B, 898353B, 954458B, 970987B | HDPE Bottle: 35 mL | 8/13/2025 |
| National Laboratory Certification Program | 045784B, 052798B, 057593B, 098212B, 100893B, 101142B, 180904B, 216010B, 273557B, 276954B, 288342B, 368630B, 388064B, 435990B, 438949B, 471911B, 482770B, 502619B, 532590B, 536276B, 551023B, 575720B, 623191B, 634009B, 647236B, 662633B, 675205B, 685451B, 689710B, 731533B, 744103B, 820031B, 855502B, 862411B, 931507B, 027777B, 119490B, 137163B, 158033B, 162620B, 244094B, 275356B, 291164B, 302291B, 312676B, 379494B, 381497B, 399175B, 423577B, 433740B, 434559B, 452118B, 536280B, 541933B, 560683B, 589996B, 602983B, 630257B, 659372B, 678582B, 700844B, 741401B, 756887B, 823112B, 834359B, 875111B, 876818B, 877156B, 881128B, 998279B, 037014B, 039673B, 045770B, 058136B, 065317B, 066839B, 132937B, 170901B, 175168B, 210176B, 229910B, 241586B, 273502B, 284310B, 284718B, 289955B, 306823B, 399116B, 475395B, 499112B, 545017B, 548515B, 593510B, 651653B, 660732B, 664479B, 694851B, 721298B, 733106B, 770235B, 786980B, 907019B, 920045B, 990726B, 996913B, 021162B, 087866B, 183065B, 189337B, 205052B, 234816B, 260972B, 271462B, 308292B, 323664B, 345750B, 394883B, 437939B, 466877B, 495588B, 517011B, 518096B, 519701B, 550619B, 614606B, 648570B, 682661B, 703108B, 724890B, 732560B, 732619B, 778313B, 792989B, 808760B, 843703B, 876417B, 888383B, 904377B, 910460B, 957244B, 055473A, 062795A, 091960A, 095654A, 103689A, 121192A, 152490A, 343605A, 380438A, 431234A, 440090A, 443804A, 493914A, 498294A, 549495A, 553148A, 583854A, 592585A, 614725A, 634559A, 663404A, 691749A, 740783A, 745137A, 753250A, 767767A, 778930A, 796137A, 804117A, 818517A, 838861A, 895186A, 905662A, 934214A, 979252A | HDPE Bottle: 35 mL | 8/13/2025 |
| ( printed page 13632) | | | |
| National Laboratory Certification Program | 074055A, 103111A, 119335A, 253010A, 284037A, 285200A, 307883A, 312834A, 321193A, 331790A, 337173A, 387539A, 404275A, 449403A, 476817A, 527683A, 531288A, 605622A, 613189A, 634257A, 651887A, 652077A, 672726A, 677614A, 696727A, 718250A, 833229A, 834573A, 843020A, 898432A, 951122A, 976028A, 979580A, 984005A, 985648A, 021619A, 040036A, 042253A, 047178A, 067336A, 118948A, 168728A, 177066A, 249348A, 265410A, 268548A, 278997A, 308487A, 323939A, 329064A, 460527A, 583497A, 617274A, 618834A, 626872A, 658023A, 674192A, 684034A, 710223A, 721689A, 730015A, 792299A, 799879A, 848331A, 864583A, 867060A, 873822A, 877391A, 967406A, 979251A, 000665A, 025017A, 055959A, 067706A, 122536A, 146733A, 154141A, 172901A, 189669A, 270190A, 317074A, 381166A, 389562A, 394605A, 404688A, 478269A, 480736A, 489585A, 513162A, 520168A, 526012A, 571094A, 574081A, 582332A, 607700A, 625252A, 685985A, 807835A, 851074A, 854031A, 854264A, 891374A, 934897A, 959220A, 990476A, 018312A, 025641A, 031396A, 083193A, 099900A, 104132A, 111257A, 141712A, 150760A, 192893A, 202322A, 226723A, 251858A, 264258A, 268600A, 317802A, 354305A, 388382A, 469706A, 540684A, 554382A, 581932A, 583177A, 593106A, 699066A, 716424A, 728547A, 775320A, 784436A, 822127A, 862509A, 904228A, 911402A, 912819A, 934539A | HDPE Bottle: 35 mL | 8/13/2025 |
| National Laboratory Certification Program | 12666-143-30301 | HDPE Vial: 3 mL | 3/6/2025 |
| National Laboratory Certification Program | 12666-143-30302 | HDPE Vial: 3 mL | 3/6/2025 |
| National Laboratory Certification Program | 12666-143-30303 | HDPE Vial: 3 mL
HDPE Vial: 3 mL | 3/6/2025 |
| National Laboratory Certification Program | 12666-143-30304 | HDPE Vial: 3 mL | 3/6/2025 |
| National Laboratory Certification Program | 12666-143-30305 | HDPE Vial: 3 mL | 3/6/2025 |
| National Laboratory Certification Program | 12666-143-30306 | HDPE Vial: 3 mL | 3/6/2025 |
| National Laboratory Certification Program | 127972A, 129253A, 157500A, 162396A, 164373A, 195102A, 251623A, 292781A, 297839A, 305609A, 349662A, 351685A, 418387A, 425259A, 443116A, 469054A, 497169A, 598078A, 650309A, 681409A, 689544A, 705767A, 741096A, 757116A, 792683A, 805477A, 822731A, 856956A, 861441A, 883543A, 903124A, 903264A, 911065A, 958405A, 999965A, 092669A, 093912A, 113643A, 120299A, 187578A, 224713A, 282085A, 290486A, 303537A, 403406A, 407127A, 410750A, 413786A, 418464A, 422026A, 569177A, 597899A, 604333A, 607705A, 611430A, 616383A, 626203A, 758029A, 799149A, 822057A, 827055A, 849915A, 866988A, 885741A, 889674A, 946229A, 950892A, 965105A, 976156A, 988441A, 011680A, 017661A, 080304A, 095217A, 109225A, 114025A, 138442A, 206042A, 228759A, 233184A, 308871A, 340469A, 413044A, 448867A, 478672A, 501400A, 505846A, 536930A, 590200A, 604209A, 631483A, 634395A, 725480A, 741966A, 765032A, 766257A, 796397A, 798459A, 818295A, 843407A, 848811A, 849883A, 911465A, 921657A, 952764A, 017944A, 040220A, 050432A, 079752A, 082110A, 086038A, 092088A, 098069A, 137512A, 156757A, 171216A, 211808A, 226869A, 233495A, 318540A, 327851A, 354016A, 395600A, 485757A, 486285A, 510005A, 514619A, 547594A, 566208A, 569696A, 585093A, 708168A, 709648A, 756379A, 780888A, 845265A, 862932A, 885795A, 910079A, 928497A | HDPE Bottle: 35 mL | 8/13/2025 |
| National Laboratory Certification Program | 3001526A, 3018238A, 3096101A, 3110680A, 3113769A, 3154844A, 3173916A, 3223482A, 3243510A, 3251713A, 3266043A, 3327699A, 3335519A, 3376571A, 3377786A, 3416295A, 3429118A, 3502245A, 3550307A, 3583264A, 3632642A, 3633818A, 3761575A, 3777806A, 3808198A, 3840016A, 3845334A, 3870626A, 3882358A, 3917156A | HDPE Vial: 3 mL | 3/6/2025 |
| National Laboratory Certification Program | 3001561B, 3111394B, 3164261B, 3181381B, 3217659B, 3227574B, 3228185B, 3246578B, 3256519B, 3266885B, 3274430B, 3287200B, 3424866B, 3432366B, 3437934B, 3460352B, 3481298B, 3534668B, 3592630B, 3623211B, 3629152B, 3759816B, 3771088B, 3805172B, 3848708B, 3890789B, 3891851B, 3899493B, 3900343B, 3947408B | HDPE Vial: 3 mL | 3/6/2025 |
| National Laboratory Certification Program | 3001667B, 3004957B, 3031723B, 3083566B, 3150408B, 3262567B, 3270737B, 3288994B, 3290699B, 3336123B, 3347362B, 3371622B, 3502194B, 3566045B, 3573387B, 3608174B, 3672038B, 3681979B, 3729211B, 3794001B, 3800765B, 3805195B, 3821092B, 3852132B, 3873873B, 3879475B, 3923970B, 3931439B, 3987782B, 3988045B | HDPE Vial: 3 mL | 3/6/2025 |
| National Laboratory Certification Program | 3002885A, 3032516A, 3059502A, 3075601A, 3265588A, 3308788A, 3330657A, 3342909A, 3365597A, 3371721A, 3416858A, 3436675A, 3439719A, 3441349A, 3457316A, 3492077A, 3573177A, 3576706A, 3596782A, 3619408A, 3636601A, 3681393A, 3709882A, 3743512A, 3746323A, 3774507A, 3805268A, 3806370A, 3875820A, 3904297A | HDPE Vial: 3 mL | 3/6/2025 |
| National Laboratory Certification Program | 3003529A, 3016329A, 3020530A, 3100060A, 3249119A, 3288976A, 3296457A, 3305000A, 3352118A, 3354787A, 3443033A, 3456936A, 3475272A, 3517958A, 3585346A, 3601671A, 3602096A, 3684145A, 3712181A, 3733342A, 3740081A, 3752980A, 3768699A, 3772330A, 3815885A, 3818589A, 3848435A, 3936065A, 3948826A, 3997458A | HDPE Vial: 3 mL | 3/6/2025 |
| ( printed page 13633) | | | |
| National Laboratory Certification Program | 3005594A, 3016355A, 3023157A, 3035514A, 3111073A, 3131838A, 3133767A, 3150842A, 3161299A, 3164878A, 3187011A, 3193620A, 3195470A, 3237729A, 3282426A, 3401793A, 3447639A, 3463783A, 3513508A, 3656013A, 3661234A, 3705959A, 3717940A, 3762813A, 3776672A, 3796275A, 3813144A, 3867683A, 3883090A, 3972739A | HDPE Vial: 3 mL | 3/6/2025 |
| National Laboratory Certification Program | 3005883A, 3073389A, 3076401A, 3089690A, 3188478A, 3202906A, 3236799A, 3287040A, 3412094A, 3416181A, 3444322A, 3449332A, 3472844A, 3489572A, 3494862A, 3497108A, 3533455A, 3632861A, 3639069A, 3652583A, 3668064A, 3691540A, 3721917A, 3863022A, 3864728A, 3867894A, 3878930A, 3886649A, 3925271A, 3934297A | HDPE Vial: 3 mL | 3/6/2025 |
| National Laboratory Certification Program | 3007068A, 3051651A, 3082943A, 3131111A, 3151718A, 3163593A, 3165852A, 3189585A, 3207235A, 3284335A, 3346441A, 3432748A, 3445386A, 3498509A, 3556658A, 3593957A, 3594024A, 3629943A, 3685516A, 3738840A, 3739632A, 3791378A, 3800013A, 3822762A, 3848422A, 3874346A, 3895574A, 3916052A, 3916261A, 3927510A | HDPE Vial: 3 mL | 3/6/2025 |
| National Laboratory Certification Program | 3008328A, 3021124A, 3034987A, 3043899A, 3047626A, 3075399A, 3094586A, 3109621A, 3118330A, 3136466A, 3160629A, 3168697A, 3186473A, 3234782A, 3257909A, 3294571A, 3422337A, 3459515A, 3519968A, 3531841A, 3578361A, 3611182A, 3624409A, 3644730A, 3652651A, 3784145A, 3799996A, 3804149A, 3822500A, 3994427A | HDPE Vial: 3 mL | 3/6/2025 |
| National Laboratory Certification Program | 3008973B, 3100443B, 3115009B, 3159703B, 3218595B, 3249504B, 3269672B, 3301958B, 3307598B, 3336923B, 3406713B, 3460251B, 3471241B, 3536399B, 3539176B, 3549507B, 3583097B, 3589775B, 3630389B, 3705792B, 3751918B, 3755548B, 3764678B, 3778759B, 3832537B, 3896484B, 3903120B, 3949462B, 3991305B, 3996884B | HDPE Vial: 3 mL | 3/6/2025 |
| National Laboratory Certification Program | 3009600A, 3031020A, 3032934A, 3038639A, 3074315A, 3089928A, 3090809A, 3096337A, 3243223A, 3248521A, 3312725A, 3362289A, 3521717A, 3528430A, 3553561A, 3566355A, 3581050A, 3593952A, 3614765A, 3614805A, 3617959A, 3632040A, 3672984A, 3679343A, 3703755A, 3759819A, 3763942A, 3792773A, 3865884A, 3876296A | HDPE Vial: 3 mL | 3/6/2025 |
| National Laboratory Certification Program | 3010304B, 3025326B, 3078460B, 3115817B, 3138994B, 3188021B, 3227363B, 3237238B, 3247720B, 3323070B, 3377569B, 3446404B, 3454987B, 3488568B, 3514486B, 3552661B, 3576522B, 3581447B, 3604192B, 3630116B, 3647127B, 3664750B, 3688368B, 3693418B, 3707739B, 3724205B, 3729976B, 3753367B, 3753846B, 3904709B | HDPE Vial: 3 mL | 3/6/2025 |
| National Laboratory Certification Program | 3010418A, 3041985A, 3072104A, 3093023A, 3148452A, 3159815A, 3185731A, 3205915A, 3257074A, 3264094A, 3456439A, 3518514A, 3542534A, 3560869A, 3576394A, 3589917A, 3590551A, 3614060A, 3619161A, 3632860A, 3682429A, 3688481A, 3722693A, 3744342A, 3779857A, 3816604A, 3900965A, 3926308A, 3935189A, 3962414A | HDPE Vial: 3 mL | 3/6/2025 |
| National Laboratory Certification Program | 3011561A, 3016349A, 3028033A, 3040588A, 3041461A, 3049999A, 3057399A, 3069276A, 3094499A, 3098662A, 3106809A, 3109485A, 3110758A, 3143343A, 3157460A, 3173247A, 3173735A, 3200753A, 3204816A, 3223181A, 3226146A, 3226393A, 3231838A, 3232362A, 3253939A, 3254555A, 3269806A, 3311940A, 3318480A, 3326919A, 3340327A, 3343495A, 3347294A, 3359788A, 3367959A, 3372567A, 3372771A, 3372775A, 3376958A, 3511322A, 3533282A, 3566880A, 3569519A, 3587528A, 3590989A, 3600383A, 3606015A, 3614978A, 3653049A, 3655349A, 3660205A, 3661971A, 3667601A, 3672435A, 3673190A, 3676936A, 3677036A, 3677911A, 3681151A, 3682004A, 3684617A, 3686876A, 3687842A, 3689103A, 3717560A, 3723195A, 3733223A, 3737827A, 3746190A, 3763303A, 3763680A, 3765489A, 3766764A, 3798667A, 3806633A, 3807874A, 3848321A, 3857100A, 3858494A, 3860624A, 3887617A, 3908793A, 3912976A, 3915438A, 3923336A, 3946249A, 3946891A, 3960819A, 3982610A, 3986290A | HDPE Vial: 3 mL | 3/6/2025 |
| National Laboratory Certification Program | 3012164A, 3028858A, 3047759A, 3064683A, 3098352A, 3122968A, 3144589A, 3158504A, 3210485A, 3256135A, 3285326A, 3356526A, 3374191A, 3379877A, 3421652A, 3448389A, 3483864A, 3521336A, 3527033A, 3534663A, 3570676A, 3694196A, 3737270A, 3744955A, 3792333A, 3864328A, 3879755A, 3889849A, 3905323A, 3923993A | HDPE Vial: 3 mL | 3/6/2025 |
| National Laboratory Certification Program | 3012928A, 3107715A, 3151473A, 3167204A, 3169700A, 3404495A, 3410159A, 3419668A, 3429456A, 3439515A, 3451900A, 3477555A, 3509677A, 3530532A, 3604662A, 3619597A, 3647490A, 3681149A, 3704067A, 3713678A, 3714438A, 3809460A, 3813614A, 3825421A, 3854787A, 3861027A, 3894183A, 3917584A, 3930330A, 3985400A | HDPE Vial: 3 mL | 3/6/2025 |
| National Laboratory Certification Program | 3016707A, 3043599A, 3066343A, 3072567A, 3092950A, 3169068A, 3170077A, 3229867A, 3233703A, 3247776A, 3257763A, 3293091A, 3310725A, 3344792A, 3360359A, 3375880A, 3411473A, 3543435A, 3549713A, 3622398A, 3652679A, 3670107A, 3710967A, 3715797A, 3723645A, 3794547A, 3803731A, 3847733A, 3887552A, 3927095A | HDPE Vial: 3 mL | 3/6/2025 |
| National Laboratory Certification Program | 3020724B, 3068816B, 3093998B, 3142895B, 3164819B, 3165350B, 3186749B, 3238252B, 3344018B, 3359791B, 3360777B, 3376684B, 3472813B, 3508578B, 3560740B, 3606041B, 3680246B, 3689404B, 3690182B, 3693175B, 3713958B, 3734229B, 3748433B, 3785687B, 3815477B, 3820402B, 3821647B, 3897005B, 3897999B, 3927383B | HDPE Vial: 3 mL | 3/6/2025 |
| National Laboratory Certification Program | 3021219A, 3023186A, 3086733A, 3183679A, 3308343A, 3349847A, 3350664A, 3358810A, 3412053A, 3499706A, 3506812A, 3528745A, 3560766A, 3637005A, 3645598A, 3693016A, 3742855A, 3760817A, 3761522A, 3763868A, 3786560A, 3822983A, 3831473A, 3850334A, 3876575A, 3898313A, 3969590A, 3985727A, 3988177A, 3994387A | HDPE Vial: 3 mL | 3/6/2025 |
| ( printed page 13634) | | | |
| National Laboratory Certification Program | 3023523A, 3051357A, 3093271A, 3133012A, 3142602A, 3190390A, 3221282A, 3240233A, 3255293A, 3314116A, 3322683A, 3362689A, 3413976A, 3435316A, 3481683A, 3511738A, 3526090A, 3548126A, 3590508A, 3601231A, 3631781A, 3665199A, 3702464A, 3714833A, 3738664A, 3739140A, 3743106A, 3819163A, 3916445A, 3953054A | HDPE Vial: 3 mL | 3/6/2025 |
| National Laboratory Certification Program | 3029689A, 3096300A, 3138534A, 3140906A, 3142275A, 3228996A, 3249275A, 3321921A, 3346358A, 3359278A, 3409480A, 3444581A, 3453800A, 3591139A, 3597481A, 3600495A, 3643302A, 3670536A, 3684303A, 3684351A, 3713947A, 3737530A, 3792369A, 3801851A, 3865773A, 3915873A, 3952118A, 3967932A, 3976950A, 3998618A | HDPE Vial: 3 mL | 3/6/2025 |
| National Laboratory Certification Program | 3030692A, 3050404A, 3078848A, 3141019A, 3220907A, 3237827A, 3281412A, 3356783A, 3393221A, 3415748A, 3432054A, 3441998A, 3450733A, 3476839A, 3486417A, 3534469A, 3603256A, 3615282A, 3622773A, 3630797A, 3805670A, 3819402A, 3820186A, 3843535A, 3844702A, 3870160A, 3914649A, 3945943A, 3948137A, 3973675A | HDPE Vial: 3 mL | 3/6/2025 |
| National Laboratory Certification Program | 3033655A, 3148732A, 3158615A, 3166410A, 3182571A, 3195724A, 3205849A, 3256279A, 3261299A, 3319856A, 3339323A, 3352621A, 3434751A, 3527434A, 3531401A, 3542663A, 3561629A, 3634729A, 3641383A, 3728378A, 3754081A, 3770816A, 3821409A, 3829473A, 3839234A, 3888691A, 3889962A, 3899960A, 3931049A, 3982759A | HDPE Vial: 3 mL | 3/6/2025 |
| National Laboratory Certification Program | 3036095A, 3058266A, 3067134A, 3077253A, 3100715A, 3155045A, 3251374A, 3277984A, 3411888A, 3477837A, 3485813A, 3492014A, 3496509A, 3509733A, 3524999A, 3583845A, 3591371A, 3616636A, 3650222A, 3660650A, 3766063A, 3795050A, 3828634A, 3848460A, 3864851A, 3891313A, 3899174A, 3899835A, 3936845A, 3950812A | HDPE Vial: 3 mL | 3/6/2025 |
| National Laboratory Certification Program | 3037408A, 3040347A, 3044188A, 3063574A, 3073540A, 3119606A, 3187449A, 3236090A, 3245391A, 3288255A, 3290954A, 3298897A, 3303332A, 3318047A, 3532772A, 3572072A, 3585782A, 3600997A, 3613741A, 3633514A, 3639066A, 3674866A, 3717326A, 3830995A, 3847077A, 3866622A, 3893252A, 3925151A, 3929107A, 3959298A | HDPE Vial: 3 mL | 3/6/2025 |
| National Laboratory Certification Program | 3046892A, 3068147A, 3091284A, 3146895A, 3180453A, 3252445A, 3253516A, 3299519A, 3315217A, 3353243A, 3428709A, 3430744A, 3506382A, 3508890A, 3525949A, 3649462A, 3676287A, 3692936A, 3847688A, 3862078A, 3873514A, 3875896A, 3909373A, 3913200A, 3925872A, 3950262A, 3952457A, 3966539A, 3969132A, 3998769A | HDPE Vial: 3 mL | 3/6/2025 |
| National Laboratory Certification Program | 3047214B, 3059446B, 3075462B, 3087247B, 3140711B, 3175259B, 3187385B, 3194697B, 3203074B, 3263404B, 3323755B, 3400102B, 3403561B, 3416679B, 3417550B, 3445008B, 3472972B, 3543431B, 3582265B, 3595428B, 3694531B, 3729663B, 3742377B, 3749390B, 3758536B, 3790884B, 3796602B, 3837347B, 3964403B, 3973081B | HDPE Vial: 3 mL | 3/6/2025 |
| National Laboratory Certification Program | 3056468A, 3060389A, 3067677A, 3089939A, 3090368A, 3128487A, 3131048A, 3213020A, 3244116A, 3293189A, 3384729A, 3453724A, 3488820A, 3493463A, 3620499A, 3653258A, 3663616A, 3716679A, 3716984A, 3728381A, 3736956A, 3754682A, 3757874A, 3789566A, 3797087A, 3817090A, 3818675A, 3824392A, 3868999A, 3948831A | HDPE Vial: 3 mL | 3/6/2025 |
| National Laboratory Certification Program | 3063984B, 3069837B, 3088589B, 3104298B, 3112383B, 3138088B, 3139808B, 3170439B, 3185297B, 3223363B, 3289529B, 3303908B, 3319607B, 3403199B, 3436529B, 3597148B, 3604470B, 3624106B, 3632206B, 3642572B, 3652629B, 3679184B, 3693998B, 3696224B, 3725661B, 3825069B, 3839338B, 3839535B, 3845283B, 3912852B | HDPE Vial: 3 mL | 3/6/2025 |
| National Laboratory Certification Program | 3064074B, 3084328B, 3095680B, 3118068B, 3137565B, 3159024B, 3183994B, 3199215B, 3202427B, 3215566B, 3226641B, 3248858B, 3261455B, 3345736B, 3363433B, 3395764B, 3413880B, 3519492B, 3562005B, 3594280B, 3611395B, 3625777B, 3635526B, 3636762B, 3646254B, 3714935B, 3725057B, 3836015B, 3908082B, 3961930B | HDPE Vial: 3 mL | 3/6/2025 |
| National Laboratory Certification Program | 3073287A, 3076151A, 3132290A, 3158106A, 3192850A, 3197787A, 3202479A, 3240032A, 3285442A, 3323025A, 3378085A, 3417366A, 3433920A, 3449269A, 3459500A, 3488327A, 3546931A, 3550334A, 3576142A, 3654086A, 3691492A, 3736040A, 3773050A, 3843648A, 3851418A, 3862048A, 3896474A, 3916434A, 3935786A, 3989510A | HDPE Vial: 3 mL | 3/6/2025 |
| National Laboratory Certification Program | 3083202A, 3107453A, 3115422A, 3155646A, 3253665A, 3373400A, 3392808A, 3404301A, 3404444A, 3466365A, 3478874A, 3513958A, 3551738A, 3587072A, 3600256A, 3605299A, 3643249A, 3681391A, 3683982A, 3717874A, 3727571A, 3826732A, 3843814A, 3846661A, 3851708A, 3891507A, 3932641A, 3949867A, 3953051A, 3995831A | HDPE Vial: 3 mL | 3/6/2025 |
| National Laboratory Certification Program | 3091191A, 3110756A, 3120543A, 3134482A, 3169652A, 3172928A, 3184518A, 3240486A, 3258786A, 3271735A, 3283951A, 3371600A, 3447571A, 3457571A, 3669166A, 3673703A, 3678508A, 3681083A, 3691860A, 3703355A, 3818629A, 3887683A, 3899815A, 3914520A, 3928682A, 3946169A, 3953024A, 3966471A, 3973841A, 3976420A | HDPE Vial: 3 mL | 3/6/2025 |
| o2si smart solutions | Sports Performance Supplement Internal Standard, 0.5-50 ug/mL, 1 mL | Amber Glass Ampule: 1 mL | 9/12/2025 |
| o2si smart solutions | Sports Performance Supplement Internal Standard, 10-100 ug/mL, 1 mL | Glass Ampule: 1 ml | 8/12/2025 |
| o2si smart solutions | Sports Supplement Adulterant Kit, 10-50 ug/mL, 1 mL G34-140492-Kit-2 | Kit: 2 Ampules, 1 mL each | 8/22/2025 |
| o2si smart solutions | Sports Supplement Adulterant Kit, 100 ug/mL, 1 mL G34-140492-Kit | Kit: 2 Ampules, 1 mL each | 8/22/2025 |
| o2si smart solutions | Sports Supplement Adulterant Solution, 10-50 ug/mL, 1 mL G34-140492-02 | Amber Ampule: 1 mL | 8/22/2025 |
| ( printed page 13635) | | | |
| o2si smart solutions | Sports Supplement Adulterant Solution, 100 ug/mL, 1 mL G34-140492-03 | Amber Ampule: 1 mL | 8/22/2025 |
| o2si smart solutions | Weight Loss Adulterant Solution, 5, 10, and 20 ug/mL, 1 mL | Glass Ampule: 1 ml | 8/12/2025 |
| o2si smart solutions | Weight Loss Supplement Internal Standard, 10-200ug.mL, 1 ml | Amber ampule: 1 mL | 4/28/2025 |
| o2si smart solutions | Weight Loss Supplement Internal Standard, 10-200ug/mL, 1 ml | Amber Glass Ampule: 1 mL | 9/12/2025 |
| Restek Corporation | Cannabinoids 11 (1000) standard | Glass Vial, 0.5 mL | 5/15/2025 |
| Restek Corporation | Cannabinoids 11 (1000) standard | Glass Vial, 0.7 mL | 5/15/2025 |
| Restek Corporation | Cannabinoids 11 (1000) standard | Glass Vial: 0.6 mL | 5/15/2025 |
| Restek Corporation | Custom Meprobamate Standard | Glass Ampoule: 5 mL | 8/14/2025 |
| Restek Corporation | Product and Reactor Chloral Hydrate Standard | Glass ampule: 2.3 mL | 11/11/2025 |
| Restek Corporation | Product and Reactor Samples Standard—Rev 2 | Glass vial: 0.8 mL | 4/28/2025 |
| Restek Corporation | Product and Reactor Samples Standard—Rev 2 | Glass ampule: 2.3 mL | 5/8/2025 |
| RTI International | EQAP Round: RTI-#25-4 Sample: S13042 | HDPE bottles: 25 mL each | 4/16/2025 |
| RTI International | EQAP Round: RTI-#25-4 Sample: S13115 | HDPE bottles: 25 mL each | 4/16/2025 |
| RTI International | EQAP Round: RTI-#25-4 Sample: S13129 | HDPE bottles: 25 mL each | 4/16/2025 |
| RTI International | EQAP Round: RTI-#25-4 Sample: S13139 | HDPE bottles: 25 mL each | 4/16/2025 |
| RTI International | EQAP Round: RTI-#25-4 Sample: S13147 | HDPE bottles: 25 mL each | 4/16/2025 |
| RTI International | EQAP Round: RTI-#25-4 Sample: S13174 | HDPE bottles: 25 mL each | 4/16/2025 |
| RTI International | EQAP Round: RTI-#25-4 Sample: S13219 | HDPE bottles: 25 mL each | 4/16/2025 |
| RTI International | EQAP Round: RTI-#25-4 Sample: S13238 | HDPE bottles: 25 mL each | 4/16/2025 |
| RTI International | EQAP Round: RTI-#25-4 Sample: S13265 | HDPE bottles: 25 mL each | 4/16/2025 |
| RTI International | EQAP Round: RTI-#25-4 Sample: S13268 | HDPE bottles: 25 mL each | 4/16/2025 |
| RTI International | EQAP Round: RTI-#25-4 Sample: S13274 | HDPE bottles: 25 mL each | 4/16/2025 |
| RTI International | EQAP Round: RTI-#25-4 Sample: S13315 | HDPE bottles: 25 mL each | 4/16/2025 |
| RTI International | EQAP Round: RTI-#25-4 Sample: S13393 | HDPE bottles: 25 mL each | 4/16/2025 |
| RTI International | EQAP Round: RTI-#25-4 Sample: S13396 | HDPE bottles: 25 mL each | 4/16/2025 |
| RTI International | EQAP Round: RTI-#25-4 Sample: S13440 | HDPE bottles: 25 mL each | 4/16/2025 |
| RTI International | EQAP Round: RTI-#25-4 Sample: S13471 | HDPE bottles: 25 mL each | 4/16/2025 |
| RTI International | EQAP Round: RTI-#25-4 Sample: S13576 | HDPE bottles: 25 mL each | 4/16/2025 |
| RTI International | EQAP Round: RTI-#25-4 Sample: S13642 | HDPE bottles: 25 mL each | 4/16/2025 |
| RTI International | EQAP Round: RTI-#25-4 Sample: S13657 | HDPE bottles: 25 mL each | 4/16/2025 |
| RTI International | EQAP Round: RTI-#25-4 Sample: S13658 | HDPE bottles: 25 mL each | 4/16/2025 |
| RTI International | EQAP Round: RTI-#25-4 Sample: S13707 | HDPE bottles: 25 mL each | 4/16/2025 |
| RTI International | EQAP Round: RTI-#25-4 Sample: S13709 | HDPE bottles: 25 mL each | 4/16/2025 |
| RTI International | EQAP Round: RTI-#25-4 Sample: S13739 | HDPE bottles: 25 mL each | 4/16/2025 |
| RTI International | EQAP Round: RTI-#25-4 Sample: S13752 | HDPE bottles: 25 mL each | 4/16/2025 |
| RTI International | EQAP Round: RTI-#25-4 Sample: S13837 | HDPE bottles: 25 mL each | 4/16/2025 |
| RTI International | EQAP Round: RTI-#25-4 Sample: S13853 | HDPE bottles: 25 mL each | 4/16/2025 |
| RTI International | EQAP Round: RTI-#25-4 Sample: S13886 | HDPE bottles: 25 mL each | 4/16/2025 |
| RTI International | EQAP Round: RTI-#25-4 Sample: S13896 | HDPE bottles: 25 mL each | 4/16/2025 |
| RTI International | EQAP Round: RTI-#25-4 Sample: S13917 | HDPE bottles: 25 mL each | 4/16/2025 |
| RTI International | EQAP Round: RTI-#25-4 Sample: S13981 | HDPE bottles: 25 mL each | 4/16/2025 |
| Siemans Healthcare Diagnostics, Inc | Advia Chemistry Toxicology Calibrator 1 | Kit: 1 vial, 5 mL | 12/23/2024 |
| Siemans Healthcare Diagnostics, Inc | Advia Chemistry Toxicology Calibrator 2 | Kit: 1 vial, 5 mL | 12/23/2024 |
| Siemans Healthcare Diagnostics, Inc | Advia Chemistry Toxicology Calibrator 3 | Kit: 1 vial, 5 mL | 12/23/2024 |
| Siemans Healthcare Diagnostics, Inc | Advia Chemistry Toxicology Calibrator 4 | Kit: 1 vial, 5 mL | 12/23/2024 |
The Assistant Administrator has found that each of the compounds, mixtures, and preparations described in Chart II, below, is not consistent with the criteria stated in 21 U.S.C. 811(g)(3)(B) and in 21 CFR 1308.23. Accordingly, the Assistant Administrator has determined that the chemical preparations or mixtures generally described in Chart II, below, and specifically described in the application materials received by DEA, are not exempt from application of any part of the CSA or from application of any part of the CFR, with regard to the requested exemption pursuant to 21 CFR 1308.23, as of the date that was provided in the determination letters to the individual requesters.
| Supplier name | Product name | Form | Application
date |
| --- | --- | --- | --- |
| Cayman Chemical Company | para-methyl Acetyl fentanyl (hydrochloride) (exempt preparation) 1 mg/mL in methanol | Glass vial: 1 mL | 4/28/2025 |
| Cayman Chemical Company | ortho-methyl Acetyl fentanyl (hydrochloride) (exempt preparation) 1 mg/mL in methanol | Glass vial: 1 mL | 4/28/2025 |
| Cayman Chemical Company | meta-methyl Acetyl fentanyl (hydrochloride) (exempt preparation) 1 mg/mL in methanol | Glass vial: 1 mL | 4/28/2025 |
| Cayman Chemical Company | meta-Methylfentanyl-d5 (hydrochloride) (exempt preparation) 1 mg/mL in methanol | Glass vial: 1 mL | 4/28/2025 |
| Cayman Chemical Company | para-Methylfentanyl-d5 (hydrochloride) (exempt preparation) 1 mg/mL in methanol | Glass vial: 1 mL | 4/28/2025 |
| Cayman Chemical Company | ortho-Fluorofentanyl-d5 (hydrochloride) (exempt preparation) 1 mg/mL in methanol | Glass vial: 1 mL | 4/28/2025 |
| Cayman Chemical Company | meta-Fluorofentanyl-d5 (hydrochloride) (exempt preparation) 1 mg/mL in methanol | Glass vial: 1 mL | 4/28/2025 |
| Restek Corporation | Cannabinoids 11 (1000) Standard | Glass Vial: 0.8 mL | 5/12/2025 |
| Bionostics, Inc | Intermediate Process Product State 1 (SAF03103) | Nalgene bottle: 20 L | 4/1/2025 |
| ( printed page 13636) | | | |
| Bionostics, Inc | Intermediate Process Product State 2 (SAA03027) | 3500 Glass ampoules: 0.5 mL each | 4/1/2025 |
| LGC-TRC | p-Fluoro Fentanyl (1.0mg/ml in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC-TRC | Acetyl Fentanyl (1.0 mg/mL in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC-TRC | 4-Fluoroisobutyrylfentanyl (1.0mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC-TRC | Alfentanil Hydrochloride (1 mg/ml in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC-TRC | Alfentanil-d3 Hydrochloride (1.0 mg/mL in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC-TRC | Remifentanil-13C6 Hydrochloride (1.0mg/ml in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC-TRC | Remifentanil-13C6 Hydrochloride (1mg/ml in Acetonitrile) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC-TRC | Carfentanil (1.0mg/ml in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC-TRC | Clonazepam (1.0 mg/mL in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC-TRC | Alprazolam (1mg/mL in Methanol) | Glass ampoule: 1 mL | 4/16/2025 |
| LGC-Lipomed | LSD (d-Lysergic acid N,N-diethylamide), 0.1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 7/24/2025 |
| LGC-Lipomed | LSD (d-Lysergic acid N,N-diethylamide), 1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 7/24/2025 |
| LGC-Lipomed | Sufentanil, 1mg/ml in Methanol | Glass Ampule: 1 ml | 8/5/2025 |
| LGC-Lipomed | Iso-LSD, 0.1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 8/14/2025 |
| LGC-Lipomed | Iso-LSD, 1mg/ml in Acetonitrile | Glass Ampule: 1 ml | 8/14/2025 |
| Cayman Chemical Company | Methylfentanyl Isomer Mixture (100 µg/mL ea. in methanol) | Glass Ampule: 1 mL | 10/1/2025 |
| Cayman Chemical Company | Methylfentanyl Isomer Mixture (50 µg ea. in methanol) | Glass Ampule: 1 mL | 10/1/2025 |
| Cayman Chemical Company | Fluorofentanyl Isomer Mixture (100 µg ea. in methanol) | Glass Ampule: 1 mL | 10/1/2025 |
| Cayman Chemical Company | Fluorofentanyl Isomer Mixture (50 µg ea. in methanol) | Glass Ampule: 1 mL | 10/1/2025 |
| Absolute Standards, Inc | N-desethyl Etonitazene PT, 1-100 ug/mL, in Ethanol | Glass Ampule: 1 ml | 10/15/2025 |
| Microgenics Corporation | Ctrl MD Clin Low AlqtdCtrl MD Clinical Hi Alqt, Catalog number: 10007727 | Glass bottle: 16-36 L; Plastic Bottle: 20-105 L | 3/3/2025 |
| Microgenics Corporation | Ctrl MD Clinical Hi Alqt, Catalog number: 10007728 | Glass bottle: 16-36 L; Plastic Bottle: 20-105 L | 3/3/2025 |
| Microgenics Corporation | Ctrl MD Low BCI, Catalog number: 1552 | Glass bottle: 8-36 L; Plastic Bottle: 10-105 L | 3/3/2025 |
| Microgenics Corporation | Ctrl MD High BCI, Catalog number: 1554 | Glass bottle: 4-36 L; Plastic Bottle: 5-105 L | 3/3/2025 |
| Microgenics Corporation | Ctrl MD Low Bulk BCI, Catalog number: 1590 | Glass bottle: 8-36 L; Plastic Bottle: 10-105 L | 3/3/2025 |
| Microgenics Corporation | Ctrl MD High Bulk BCI, Catalog number: 1596 | Glass bottle: 4-36 L; Plastic Bottle: 5-80 L | 3/3/2025 |
| Microgenics Corporation | Cal Opiate 300ng BCI, Catalog number: 1601 | Glass bottle: 36 L; Plastic Bottle: 43 L | 3/3/2025 |
| Microgenics Corporation | Cal Opiate 1000ng BCI, Catalog number: 1603 | Glass bottle: 16-36 L; Plastic Bottle: 20-40 L | 3/3/2025 |
| Microgenics Corporation | Ctrl Opiate 225ng BCI, Catalog number: 1605 | Plastic Bottle: 50-60 L | 3/3/2025 |
| Microgenics Corporation | Ctrl Opiate 375ng BCI, Catalog number: 1607 | Glass bottle: 36 L; Plastic Bottle: 50-680 L | 3/3/2025 |
| LGC-Lipomed | LAMPA, 1mg/ml in Acetonitrile | Ampule, Amber Glass: 1 mL | 11/21/2025 |
| LGC-Lipomed | Benzodiazepines mixture 8, 0.25mg/ml in Acetonitrile | Ampule, Amber Glass: 1 mL | 11/21/2025 |
| LGC-TRC | Alfentanil Hydrochloride (1 mg/ml in Methanol) | Glass ampoule: 1 mL | 11/28/2025 |
| LGC-TRC | Carfentanil (1mg/ml in Methanol) | Glass ampoule: 1 mL | 11/28/2025 |
| LGC-TRC | p-Fluoro Fentanyl (1.0mg/ml in Methanol) | Glass ampoule: 1 mL | 11/28/2025 |
| LGC-Lipomed | Fentanyl-D5, 1mg/ml in Methanol | Glass ampule: 1 mL | 12/16/2025 |
| LGC-Lipomed | Acetylfentanyl.HCl, 1mg/ml in Methanol (as free base) | Glass ampule: 1 mL | 12/16/2025 |
| LGC-Lipomed | Butyrylfentanyl, 1mg/ml in Methanol | Glass ampule: 1 mL | 12/16/2025 |
| LGC-Lipomed | Acetylfentanyl-D5, 1mg/ml in Methanol | Glass ampule: 1 mL | 12/16/2025 |
| LGC-Lipomed | Remifentanil.HCl, 1mg/ml in Methanol (as free base) | Glass ampule: 1 mL | 12/16/2025 |
| LGC-Lipomed | Furanylfentanyl, 1mg/ml in Methanol | Glass ampule: 1 mL | 12/16/2025 |
| LGC-Lipomed | Sufentanil-D5, 1mg/ml in Methanol | Glass ampule: 1 mL | 12/16/2025 |
| LGC-Lipomed | Fentanyl.citrate, 1mg/ml in Methanol (as free base) | Glass ampule: 1 mL | 12/16/2025 |
Opportunity for Comment
Pursuant to 21 CFR 1308.23(e), any interested person may submit written comments on or objections to any chemical preparation in this order that has been approved or denied as exempt. If any comments or objections raise significant issues regarding any finding of fact or conclusion of law upon which this order is based, the Assistant Administrator will immediately suspend the effectiveness of any applicable part of this order until she may reconsider the application in light of the comments and objections filed. Thereafter, the Assistant Administrator shall reinstate, revoke, or amend his original order as she determines appropriate.
Approved Exempt Chemical Preparations Are Posted on DEA's Website
A list of all current exemptions, including those listed in this order, is available on DEA's website at http://www.DEAdiversion.usdoj.gov/schedules/exempt/exempt_chemlist.pdf. The dates of applications of all current exemptions are posted for easy reference.
Signing Authority
This document of the Drug Enforcement Administration was signed on March 4, 2026, by Assistant Administrator Cheri Oz. That document with the original signature and date is maintained by DEA. For administrative purposes only, and in compliance with requirements of the Office of the Federal Register, the undersigned DEA Federal Register Liaison Officer has been authorized to sign and submit the document in electronic format for publication, as an official document of DEA. This administrative process in no way alters the legal effect of this ( printed page 13637) document upon publication in the Federal Register.
Heather Achbach,
Federal Register Liaison Officer, Drug Enforcement Administration.
Footnotes
1.
This authority has been delegated from the Attorney General to the DEA Administrator by [28 CFR 0.100](https://www.ecfr.gov/current/title-28/section-0.100), and subsequently redelegated to the Deputy Assistant Administrator pursuant to [28 CFR 0.104](https://www.ecfr.gov/current/title-28/section-0.104) and Section 7 of the appendix to subpart R of part 0.
Back to Citation [FR Doc. 2026-05486 Filed 3-19-26; 8:45 am]
BILLING CODE 4410-09-P
Published Document: 2026-05486 (91 FR 13610)
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Courts & Legal alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when FR: Drug Enforcement Administration publishes new changes.